<!DOCTYPE article
 PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.2 20190208//EN" "JATS-archivearticle1.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="preprint"><?all-math-mml yes?><?use-mml?><?origin ukpmcpa?><front><journal-meta><journal-id journal-id-type="nlm-ta">bioRxiv</journal-id><journal-title-group><journal-title>bioRxiv : the preprint server for biology</journal-title></journal-title-group><issn pub-type="ppub"/></journal-meta><article-meta><article-id pub-id-type="manuscript">EMS158002</article-id><article-id pub-id-type="doi">10.1101/2022.11.30.518220</article-id><article-id pub-id-type="archive">PPR578867</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>A regulatory toolkit of arabinose-inducible artificial transcription factors for Gram-negative bacteria</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4630-3141</contrib-id><name><surname>Naseri</surname><given-names>Gita</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="aff" rid="A2">2</xref><xref ref-type="corresp" rid="CR1">*</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8428-3428</contrib-id><name><surname>Raasch</surname><given-names>Hannah</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8534-8388</contrib-id><name><surname>Charpentier</surname><given-names>Emmanuelle</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="aff" rid="A2">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6292-619X</contrib-id><name><surname>Erhardt</surname><given-names>Marc</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="aff" rid="A2">2</xref><xref ref-type="corresp" rid="CR1">*</xref></contrib></contrib-group><aff id="A1"><label>1</label>Institut für Biologie, Humboldt-Universität zu Berlin, Philippstrasse 13, 10115 Berlin, Germany</aff><aff id="A2"><label>2</label>Max Planck Unit for the Science of Pathogens, Charitéplatz 1, 10117 Berlin, Germany</aff><author-notes><corresp id="CR1">
<label>*</label><bold>Corresponding authors</bold>: Marc Erhardt, <email>marc.erhardt@hu-berlin.de</email>; Gita Naseri, <email>naseri@mpusp.mpg.de</email></corresp></author-notes><pub-date pub-type="nihms-submitted"><day>04</day><month>12</month><year>2022</year></pub-date><pub-date pub-type="preprint"><day>30</day><month>11</month><year>2022</year></pub-date><permissions><ali:free_to_read/><license><ali:license_ref>https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref><license-p>This work is licensed under a <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">CC BY-NC-ND 4.0 International license</ext-link>.</license-p></license></permissions><abstract><p id="P1">The Gram-negative bacteria <italic>Salmonella</italic> Typhimurium and <italic>Escherichia coli</italic> are important model organisms, powerful prokaryotic expression platforms for biotechnological applications, and pathogenic strains constitute major public health threats. To facilitate new approaches for research, biomedicine, and biotechnological applications, we developed a set of arabinose-inducible artificial transcription factors (ATFs) using CRISPR/dCas9 and <italic>Arabidopsis</italic>-derived DNA-binding proteins, allowing to control gene expression in <italic>E. coli</italic> and <italic>Salmonella</italic> over a wide inducer concentration range. As a proof-of-concept, we employed the developed ATFs to engineer a <italic>Salmonella</italic> biosen<underline>sor</underline> strain, SALSOR 0.2 (SALmonella biosenSOR 0.2), which responds to the presence of alkaloid drugs with quantifiable fluorescent output. We demonstrated that SALSOR 0.2 was able to detect the presence of the antitussive noscapine alkaloid with ~2.3-fold increased fluorescent signal over background noise compared to a previously described biosensor. Moreover, we used plant-derived ATFs to control β-carotene biosynthesis in <italic>E. coli,</italic> which resulted in ~1.6-fold higher β-carotene production compared to expression of the biosynthesis pathway using a strong constitutive promoter. The arabinose-inducible ATFs reported here thus enhance the synthetic biology repertoire of transcriptional regulatory modules that allow tuning protein expression in the Gram-negative model organisms <italic>Salmonella</italic> and <italic>E. coli.</italic></p></abstract><kwd-group><kwd>Arabinose</kwd><kwd>Artificial transcription factor</kwd><kwd><italic>Escherichia coli</italic></kwd><kwd>Gram-negative bacteria</kwd><kwd><italic>Salmonella</italic></kwd><kwd>Synthetic biology</kwd></kwd-group></article-meta></front><body><sec id="S1" sec-type="intro"><title>Introduction</title><p id="P2">Gram-negative bacteria, including <italic>Escherichia coli</italic> and <italic>Salmonella enterica,</italic> have been genetically engineered for high-titer production and secretion of difficult-to-express proteins such as conotoxins, antimicrobial peptides, and a malaria vaccine via the type-III secretion systems (T3SS)<sup><xref ref-type="bibr" rid="R1">1</xref>, <xref ref-type="bibr" rid="R2">2</xref>, <xref ref-type="bibr" rid="R3">3</xref></sup>, and have also been harnessed in cancer therapy for delivering drugs to the host cells<sup><xref ref-type="bibr" rid="R4">4</xref>, <xref ref-type="bibr" rid="R5">5</xref>, <xref ref-type="bibr" rid="R6">6</xref>, <xref ref-type="bibr" rid="R7">7</xref></sup> as they can grow in aerobic or anaerobic conditions in solid tumors<sup><xref ref-type="bibr" rid="R8">8</xref>, <xref ref-type="bibr" rid="R9">9</xref>, <xref ref-type="bibr" rid="R10">10</xref></sup>. In addition, pathogenic strains of <italic>E. coli</italic> and <italic>S. enterica</italic> are among the world’s most significant public health problems due to increasing antibiotics resistance<sup><xref ref-type="bibr" rid="R11">11</xref></sup>. Through their T3SSs, they inject effector proteins directly into host cells<sup><xref ref-type="bibr" rid="R12">12</xref>, <xref ref-type="bibr" rid="R13">13</xref></sup>. However, the complex mechanisms of the underlying gene regulatory networks (GRNs) controlling expression of many important virulence factors is poorly understood<sup><xref ref-type="bibr" rid="R14">14</xref>, <xref ref-type="bibr" rid="R15">15</xref>, <xref ref-type="bibr" rid="R16">16</xref></sup>. To understand such regulatory networks, for example, during infection or to reprogram cellular behaviors<sup><xref ref-type="bibr" rid="R17">17</xref></sup>, it is highly desirable to have robust genetic tools such as orthogonal transcriptional regulators that allow to artificially control these networks<sup><xref ref-type="bibr" rid="R18">18</xref></sup>. Toward this goal, Davis <italic>et al.</italic> (2011) have reported the development of four synthetic promoters <italic>PproA, B, C</italic>, and <italic>D,</italic> to constitutively modulate the expression of endogenous or heterologous proteins in <italic>E. coli</italic><sup><xref ref-type="bibr" rid="R19">19</xref></sup>. Later, Cooper <italic>et al</italic> (2017) applied the P<italic>pro</italic> series of promoters to improve the tunability of protein expression in <italic>Salmonella</italic><sup><xref ref-type="bibr" rid="R20">20</xref></sup>. However, employing constitutive elements to modulate the gene expression may result in a metabolic burden on the cell because the expression of heterologous proteins competes with other cellular processes and may be undesirable when an orthogonal (minimal interference with the native cellular processes) and controllable (allowing expression at the desired time) system is needed<sup><xref ref-type="bibr" rid="R21">21</xref></sup>. To address the aforementioned challenges, artificial transcription factors (ATFs) allowing for temporal, tight, and tunable gene expression are favorable. Some ATFs have been developed for synthetic biology applications in both prokaryotic and eukaryotic organisms<sup><xref ref-type="bibr" rid="R22">22</xref>, <xref ref-type="bibr" rid="R23">23</xref>, <xref ref-type="bibr" rid="R24">24</xref>, <xref ref-type="bibr" rid="R25">25</xref>, <xref ref-type="bibr" rid="R26">26</xref>, <xref ref-type="bibr" rid="R27">27</xref></sup>. However, only a limited number of ATFs are available for Gram-negative bacteria<sup><xref ref-type="bibr" rid="R24">24</xref>, <xref ref-type="bibr" rid="R25">25</xref>, <xref ref-type="bibr" rid="R26">26</xref>, <xref ref-type="bibr" rid="R27">27</xref></sup>, and to our knowledge, no dedicated ATF to control gene expression in <italic>Salmonella</italic> has been reported.</p><p id="P3">Few inducible ATFs, based on catalytically-inactive CRISPR-associated protein Cas9 (dCas9) and Cas12a (dCas12) DNA binding domains (DBDs) have been developed <italic>e.g.,</italic> in <italic>E. coli</italic><sup><xref ref-type="bibr" rid="R24">24</xref>, <xref ref-type="bibr" rid="R25">25</xref>, <xref ref-type="bibr" rid="R26">26</xref>, <xref ref-type="bibr" rid="R27">27</xref></sup> and <italic>Paenibacillus polymyxa</italic><sup><xref ref-type="bibr" rid="R28">28</xref></sup>. To activate the bacterial endogenous transcriptional machinery, these ATFs are equipped with activation domains (ADs), e.g. the omega subunit of RNA polymerase (RNAP)<sup><xref ref-type="bibr" rid="R26">26</xref></sup> or bacterial enhancer-binding proteins (bEBPs)<sup><xref ref-type="bibr" rid="R27">27</xref></sup>. However, these CRISPR/dCas-derived ATF systems require a specific genetic background that harbors deletions of the omega subunit and bEBPs, which may lead to fitness defects and might be unfavorable as the required genomic manipulation is restricted to specific host backgrounds. To overcome these issues, Dong <italic>et al.</italic> (2018) used the AD of the bacterial transcription factor SoxS to activate gene expression in <italic>E. coli</italic><sup><xref ref-type="bibr" rid="R24">24</xref></sup>.</p><p id="P4">Here, we used the same approach as described by Dong <italic>et al.</italic> (2018) to establish ATFs using dCas9 DBD and SoxS AD for tunable gene expression in <italic>Salmonella.</italic> We further evaluated a novel class of ATFs with heterologous DBDs based on plant-specific transcription factors (TFs) from <italic>Arabidopsis thaliana</italic><sup><xref ref-type="bibr" rid="R22">22</xref>, <xref ref-type="bibr" rid="R29">29</xref></sup>, combined with the SoxS AD<sup><xref ref-type="bibr" rid="R23">23</xref></sup> in order to extend our library of ATFs that allow for inducible gene expression in Gram-negative bacteria. The expression of ATFs is typically controlled by exogenous inducers. Unlike <italic>E. coli</italic><sup><xref ref-type="bibr" rid="R30">30</xref>, <xref ref-type="bibr" rid="R31">31</xref></sup>, little attention has been paid to modulating the expression level derived from the arabinose-inducible <italic>araBAD</italic> promoter (<italic>P<sub>BAD</sub></italic>) in <italic>Salmonella.</italic> Because the arabinose induction system is slightly different in <italic>Salmonella,</italic> compared to <italic>E. coli</italic><sup><xref ref-type="bibr" rid="R32">32</xref>, <xref ref-type="bibr" rid="R33">33</xref></sup>, we first genetically modified the L-arabinose (hereafter, arabinose) catabolic pathway in <italic>Salmonella enterica</italic> serovar Typhimurium resulting in ~4.5- to ~6.5-fold improved induction of <italic>P<sub>BAD</sub></italic>-derived gene expression. For our collection of arabinose-inducible ATFs, we further defined an optimal ‘arabinose induction window’ (0.01% to 0.1% arabinose) in <italic>Salmonella,</italic> that resulted in a high heterologous gene expression level with only minimal effects on bacterial growth. Finally, as a proof-of-concept for the diverse applications of ATFs, we engineered a <italic>Salmonella</italic> strain to function as a sensitive biosensor for alkaloid drugs and an <italic>E. coli</italic> strain as a microbial cell factory to produce β-carotene.</p></sec><sec id="S2" sec-type="results"><title>Results</title><sec id="S3"><title>Design of arabinose-inducible artificial transcription factors</title><p id="P5">A fundamental aim of our work was to develop inducible, heterologous regulators that allow to genetically reprogram gene regulatory networks of the Gram-negative bacteria <italic>Salmonella</italic> and <italic>E. coli.</italic> For this purpose, we generated arabinose-inducible ATFs derived from widely different DBDs: CRISPR/dCas9 and plant heterologous TFs (<xref ref-type="fig" rid="F1">Fig. 1</xref>). In order to evaluate the performances of these ATFs to induce gene expression, we developed a set of reporter and expression plasmids. Chromosomally or plasmid-derived expressed ATFs were placed under the control of <italic>P<sub>BAD</sub>.</italic> In the absence of arabinose, dimeric AraC acts as a repressor, where one monomer binds to the operator <italic>O<sub>2</sub></italic>, and another monomer binds to the <italic>I<sub>1</sub></italic> half-site in <italic>P<sub>BAD</sub></italic>, which results in the formation of a DNA loop that prevents RNAP from binding to <italic>P<sub>BAD</sub></italic>. In the presence of arabinose and upon binding of arabinose to AraC, binding of the AraC-arabinose complex to the <italic>I<sub>2</sub></italic> half-site in <italic>P<sub>BAD</sub></italic> is allosterically induced, while binding to <italic>O<sub>2</sub></italic> is decreased. In this configuration, AraC acts as activator, promoting the binding of RNAP to <italic>P<sub>BAD</sub>,</italic> which activates expression of the ATF. Next, the ATF targets its BS(s) located upstream of a weak synthetic promoter in a way that the AD contacts RNAP to promote its binding to the promoter. As a result the expression of the target gene is activated<sup><xref ref-type="bibr" rid="R34">34</xref></sup>.</p></sec><sec id="S4"><title>Development of an arabinose-based toolkit for a wide range of transcriptional outputs in <italic>Salmonella</italic></title><p id="P6">To maximize inducible gene expression from <italic>P<sub>BAD</sub>,</italic> it is necessary to identify conditions that shift the equilibrium from arabinose catabolism to maximal induction of gene expression while having a minimum effect on cellular fitness<sup><xref ref-type="bibr" rid="R10">10</xref>, <xref ref-type="bibr" rid="R31">31</xref></sup>. The <italic>P<sub>BAD</sub></italic> promoter has been extensively used to express heterologous and endogenous genes in <italic>E. coli</italic> and <italic>Salmonella.</italic> While the regulatory mechanism of the arabinose induction system has been well-characterized in <italic>E. coli</italic><sup><xref ref-type="bibr" rid="R30">30</xref>, <xref ref-type="bibr" rid="R31">31</xref>, <xref ref-type="bibr" rid="R35">35</xref></sup>, few studies have been performed on characterizing the arabinose induction system in <italic>Salmonella</italic><sup><xref ref-type="bibr" rid="R30">30</xref>, <xref ref-type="bibr" rid="R36">36</xref></sup>. In contrast to <italic>E. coli, araE</italic> is the only gene that encodes for an arabinose-specific transporter in <italic>Salmonella</italic><sup><xref ref-type="bibr" rid="R32">32</xref>, <xref ref-type="bibr" rid="R36">36</xref></sup>. In the native system, intracellular arabinose induces expression of the <italic>araBAD</italic> operon (which encodes three enzymes AraB, AraA, and AraD that convert arabinose to d-xylulose-5-phosphate to provide carbon and energy for cellular metabolisms) and of the <italic>araE</italic> gene (<xref ref-type="fig" rid="F2">Fig. 2a</xref>)<sup><xref ref-type="bibr" rid="R10">10</xref></sup>.</p><p id="P7">Like in <italic>E. coli,</italic> where addition of 0.2% arabinose results in maximal induction <italic>P<sub>BAD</sub>,</italic> 0.2% arabinose is also commonly used to induce both chromosomal and episomal <italic>P<sub>BAD</sub></italic> in <italic>S.</italic> Typhimurium<sup><xref ref-type="bibr" rid="R10">10</xref></sup>. In order to investigate the induction kinetics of the arabinose system in <italic>Salmonella,</italic> we quantified the output of a <italic>P<sub>BAD</sub></italic>-dependent fluorescent protein reporter after induction during mid-log growth phase with various concentrations of arabinose ranging from 0.00001% to 0.2% using flow cytometry (<xref ref-type="fig" rid="F2">Fig. 2b</xref> and <xref ref-type="supplementary-material" rid="SD13">Supplementary Fig. 1</xref>). Our data demonstrated that addition of 0.0005% arabinose was sufficient to maximally induce <italic>P<sub>BAD</sub></italic>-controlled expression of plasmid-encoded GFP and 0.05% arabinose for the chromosomal construct (<xref ref-type="fig" rid="F2">Fig. 2b</xref>, light grey). Additionally, deleting the <italic>araBAD</italic> operon, so that arabinose cannot be metabolized, resulted in remarkedly increased reporter protein expression compared to the <italic>araBAD</italic><sup>+</sup> strain (<xref ref-type="fig" rid="F2">Fig. 2b</xref>, dark grey). A decoupled arabinose transporter-reporter system, where <italic>araE</italic> was constitutively expressed using the relatively weak <italic>P<sub>proA</sub></italic> promoter<sup><xref ref-type="bibr" rid="R20">20</xref></sup>, resulted in maximal induction at a 10-fold lower arabinose concentration than the <italic>araE</italic><sup>+</sup> strain, where <italic>araE</italic> is under control of its native (arabinose-inducible) promoter <italic>P<sub>araE</sub></italic> (<xref ref-type="fig" rid="F2">Fig. 2b</xref>, light grey and light red, 0.01% and 0.1%). A combination of decoupled arabinose transporter-reporter system and deletion of the <italic>araBAD</italic> operon resulted in improved <italic>P<sub>BAD</sub></italic>-dependent reporter gene expression over a wide range of 0.0005% to 0.2% arabinose (<xref ref-type="fig" rid="F2">Fig. 2b and Fig. 2c</xref>, dark red).</p><p id="P8">A growth curve analysis further showed that, in presence of 0.2% arabinose, <italic>P<sub>proA</sub></italic>-controlled expression of <italic>araE</italic> (P<italic><sub>proA</sub>-araE</italic>) resulted in slower growth during early exponential growth in <italic>araBAD</italic><sup>+</sup> background (<xref ref-type="fig" rid="F2">Fig. 2d</xref>, red), compared to native, arabinose-dependent <italic>araE</italic> expression in the wild-type strain (<italic>P<sub>araE</sub>-araE</italic>) (<xref ref-type="fig" rid="F2">Fig. 2d</xref>, grey). Upon entering later growth phases (from time point 240 min), the <italic>P<sub>proA</sub>-araE</italic> strain grew better compared to the <italic>P<sub>araE</sub>-araE</italic> strain. In contrast, strong constitutive <italic>araE</italic> expression from the <italic>P<sub>proD</sub></italic> promoter resulted in similar growth compared to native arabinose-responsive <italic>araE</italic>-expression in later growth phases. These results suggest that constitutive arabinose-independent, low-level expression of AraE is optimal for an arabinose-inducible expression system. In 0.05% or lower arabinose concentrations, the growth of strains expressing <italic>araE</italic> from either native, <italic>P<sub>proA</sub></italic> or <italic>P<sub>proD</sub></italic> was similar (<xref ref-type="supplementary-material" rid="SD13">Supplementary Fig. 2a, b, and c</xref>). In high arabinose concentrations (0.1% and 0.2%), the reduced growth of strains expressing <italic>araE</italic> from either native, <italic>P<sub>proA</sub></italic> or <italic>P<sub>proD</sub></italic> is compensated upon <italic>araBAD</italic> operon deletion (<xref ref-type="fig" rid="F2">Fig. 2e, d</xref>, and <xref ref-type="supplementary-material" rid="SD13">Supplementary Fig. 2d, e, and f</xref>). The high activity of the <italic>P<sub>BAD</sub></italic>-derived reporter system (<xref ref-type="fig" rid="F2">Fig. 2b and c</xref>, highlighted in blue) with minimal growth defect (<xref ref-type="supplementary-material" rid="SD13">Supplementary Fig. 2</xref>, blue curves) implies an optimal ‘arabinose induction window’ ranging from arabinose concentrations of 0.01% to 0.1%.</p></sec><sec id="S5"><title>Arabinose-inducible CRISPR/dCas9-derived ATF library</title><p id="P9">We next established an arabinose-inducible ATF system, derived from a previously developed CRISPR/dCas9-derived ATF to activate gene expression in <italic>E. coli,</italic> employing a catalytically inactive version of <italic>Streptococcus pyogenes</italic> Cas9 (dCas9) as DBD<sup><xref ref-type="bibr" rid="R24">24</xref></sup>. The dCas9 binds to scRNA targeting the <italic>J1</italic>-derived synthetic promoter. The scRNA is fused to a MS2 hairpin sequence, which recruits a MS2 coating protein (MCP)-fused to a R93A mutant of the SoxS activator domain, which has previously been shown to effectively activate transcription<sup><xref ref-type="bibr" rid="R24">24</xref>, <xref ref-type="bibr" rid="R28">28</xref></sup>. The SoxS activator domain is recruited to dCas9 DBD by a scaffold RNA (scRNA) extended with a hairpin MS2 sequence. We, here, employed the codon-optimized dCas9 and SoxS (R93A)<sup><xref ref-type="bibr" rid="R24">24</xref></sup> system to establish an arabinose-inducible CRISPR/dCas9-derived ATF library in <italic>Salmonella</italic> (<xref ref-type="fig" rid="F3">Fig. 3a</xref>).</p><p id="P10">Dong <italic>et al.</italic> (2018)<sup><xref ref-type="bibr" rid="R24">24</xref></sup> engineered an ATF system, in which dCas9 and scRNA expression are under the control of <italic>P<sub>BAD</sub></italic> and SoxS is expressed from a constitutive promoter. The scRNAs target the regions J105, J106, J107, J108, and J111 within the <italic>J1</italic>-derived synthetic promoter, resulting in high transcriptional output<sup><xref ref-type="bibr" rid="R24">24</xref></sup>. We adapted this system and used <italic>P<sub>BAD</sub></italic> to control the expression of the relatively large dCas9 protein and SoxS AD in <italic>S.</italic> Typhimurium to minimize the negative effect of CRISPR/Cas-derived ATF expression on growth (<xref ref-type="fig" rid="F3">Fig. 3b</xref>, dark orange). In contrast, the “scRNA” cassette was expressed from the strong <italic>P<sub>BBa-J23119</sub></italic> promoter<sup><xref ref-type="bibr" rid="R38">38</xref></sup>. Additionally, dCas9 was integrated into the chromosome at the attachment site of coliphage 186 (<italic>att186</italic>)<sup><xref ref-type="bibr" rid="R39">39</xref></sup>. Expression of the CRISPR/Cas-derived ATF targeting region J105<sup><xref ref-type="bibr" rid="R24">24</xref></sup> by addition of 0.05% arabinose did not result in a growth defect of <italic>S.</italic> Typhimurium (<xref ref-type="fig" rid="F3">Fig. 3b</xref>). Our data show that <italic>P<sub>BAD</sub></italic>-controlled expression of the SoxS AD is required for the CRISPR/dCas9-derived ATF to activate reporter gene expression (<xref ref-type="fig" rid="F3">Fig. 3c</xref>, dCas9 without SoxS AD under inducing conditions (dark blue) and non-inducing conditions (light blue); dCas9 and SoxS AD under inducing conditions (dark orange) and non-inducing conditions (light orange)). Although we observed leaky reporter gene expression in the absence of the inducer, likely due to leaky expression from <italic>P<sub>BAD</sub></italic> (light orange), adding 0.05% arabinose resulted in significantly enhanced reporter gene expression (dark orange). However, expression of the reporter gene decreased dramatically and reached the background level at later growth phases (after 480 min) (<xref ref-type="fig" rid="F3">Fig. 3c</xref>, dark orange). Therefore, we performed arabinose-inducible experiments to characterize our ATFs in mid-log phase cultures.</p><p id="P11">We selected the scRNA targeting regions J105, J106, J107, J108, and J111 for further characterization. Moreover, to further extend the size of our library, we designed <italic>J1</italic> derivatives harboring two copies of J106 and J107 situated in a narrow region that is required for effective gene activation (see also <xref ref-type="fig" rid="F1">Fig. 1</xref> and <xref ref-type="fig" rid="F3">Fig. 3d</xref>, J106_2x compared to J106, and J-107_2x compared to J-107). Our driver cassette resulted in the inducible expression of CRISPR/dCas9-derived ATFs controlling expression of the fluorescent reporter protein in <italic>Salmonella</italic> (<xref ref-type="fig" rid="F3">Fig. 3d</xref>). In <italic>E. coli</italic> (<xref ref-type="supplementary-material" rid="SD13">Supplementary Fig. 3a</xref>), we were not successful in obtaining similar results for the ATFs targeting J106 and J107 as reported by Dong <italic>et al.</italic> (2018), suggesting that gene activation is likely sensitive to the established expression system in <italic>E. coli,</italic> which is consistent with prior results<sup><xref ref-type="bibr" rid="R24">24</xref></sup>. Further examination of the total population distribution showed that reporter gene expression was induced in less than 27% of <italic>E. coli</italic> cells (<xref ref-type="supplementary-material" rid="SD13">Supplementary Fig. 3b</xref>) and in more than 63% of <italic>Salmonella</italic> cells (<xref ref-type="supplementary-material" rid="SD13">Supplementary Fig. 4</xref>) in the case of strong CRISPR/Cas-derived ATF under the tested condition (<italic>E. coli</italic> 0.2% arabinose, and <italic>Salmonella</italic> 0.05% arabinose), suggesting that an inadequate amount of arabinose was used. This result highlights that developing ATFs for inducible gene expression in bacteria is challenging. However, the CRISPR/Cas9-derived ATF described here is a valuable tool for tunable gene expression in <italic>Salmonella</italic>.</p></sec><sec id="S6"><title>Arabinose-inducible plant-derived ATF library</title><p id="P12">An ideal regulatory toolkit should enable bioengineers to linearly induce gene expression over a wide dynamic range. Therefore, we aimed to extend the library of arabinose-inducible ATFs for bioengineering applications in <italic>Salmonella</italic> and <italic>E. coli.</italic> Inspired by MacDonald <italic>et al.</italic> (2021)<sup><xref ref-type="bibr" rid="R40">40</xref></sup> who demonstrated that the eukaryotic transcription factor QF from the fungus <italic>Neurospora crassa</italic> can be used in <italic>E. coli</italic> to activate transcription, we developed a new class of ATFs using heterologous TFs derived from plant for tunable gene expression in Gram-negative bacteria. Over 1000 plant-specific TFs have been identified in higher plants, grouped into diverse families according to conserved motifs in their DBD<sup><xref ref-type="bibr" rid="R41">41</xref></sup>.</p><p id="P13">In order to establish plant-derived ATFs for bacterial gene expression, full-length plant TFs GRF9, ANAC102 and JUB1-derived ATFs (which function as weak, medium and strong ATFs in yeast<sup><xref ref-type="bibr" rid="R22">22</xref>, <xref ref-type="bibr" rid="R23">23</xref>, <xref ref-type="bibr" rid="R29">29</xref></sup>), and the DBD of JUB1, JUB1<sub>DBD</sub> (which functions as medium ATF in yeast) were used. The plant TFs were fused to the bacterial SoxS(R93A) activation domain<sup><xref ref-type="bibr" rid="R24">24</xref>, <xref ref-type="bibr" rid="R28">28</xref></sup> optimized for expression in <italic>Salmonella</italic> (<xref ref-type="fig" rid="F4">Fig. 4a</xref>). We first evaluated the capacity of chromosomal or plasmid-based expression of the plant-derived ATFs under <italic>P<sub>BAD</sub></italic>-control to activate transcription in <italic>E. coli.</italic> Following the addition of inducer (0.2% arabinose), ATFs are expressed from the driver cassette (<xref ref-type="fig" rid="F4">Fig. 4a</xref>), and target two copies of their BSs within a synthetic promoter resulting in expression of the reporter sfGFP. We show that an ATF based on the full-length plant JUB1 TF, rather than only on its DBD, displays the strongest capacity to activate gene expression in <italic>E. coli</italic> (<xref ref-type="fig" rid="F4">Fig. 4b</xref>) consistent with our previous findings of the transcription activation capacity of ATFs in yeast<sup><xref ref-type="bibr" rid="R23">23</xref></sup>.</p><p id="P14">Since we observed similar transcriptional outputs for both plasmid- and chromosomally-derived expression systems, we implemented plasmid-based expression of the driver cassette in the following experiments as it may be favorable in some cases over genomic integration due to their easy manipulation. The JUB1-derived ATF, in combination with one, two, four, five and six copies of its BS was then characterized in <italic>S.</italic> Typhimurium. The obtained driver/reporter displayed an inducible range of more than ~21-fold when induced with 0.05% arabinose (<xref ref-type="fig" rid="F4">Fig. 4c</xref>). Of note, all of the ATFs resulted in higher sfGFP reporter output than the control strain expressing sfGFP from the constitutive <italic>P<sub>proA</sub></italic> promoter (<xref ref-type="fig" rid="F4">Fig. 4c</xref>, up to a ~3.5-fold, number inside the columns). All tested combinations of GRF9- or ANAC102-derived ATFs and their BSs resulted in low transcriptional outputs in <italic>Salmonella</italic> (~0.4- to ~0.6-fold of that observed for the control strain, <xref ref-type="supplementary-material" rid="SD13">Supplementary Fig. 5</xref>) despite being categorized as medium and strong regulators in yeast<sup><xref ref-type="bibr" rid="R23">23</xref></sup>. To further establish a dynamic arabinose-inducible system for precise temporal gene expression control in bacteria, we next characterized the JUB1-derived ATFs, together with two or four copies of the BS, in a S. Typhimurium background deleted for the <italic>araBAD</italic> operon and harboring a decoupled arabinose transporter-reporter system (<xref ref-type="fig" rid="F2">Fig. 2b</xref>, <italic>ΔaraBAD, P<sub>proA</sub>:: P<sub>proE</sub></italic>). The developed inducible transcription system displayed high expression strength when induced with 0.05% arabinose (~2.8-fold, <xref ref-type="fig" rid="F4">Fig. 4d</xref>,).</p></sec><sec id="S7"><title>Plant-derived ATF capacity to establish <italic>Salmonella</italic> as biosensor for alkaloid drug discovery</title><p id="P15">A key obstacle in the microbial production of high-value chemicals is to identify enzymes that can improve yield<sup><xref ref-type="bibr" rid="R42">42</xref></sup>. d’Oelsnitz <italic>et al.</italic> (2022) developed a genetically encoded biosensor based on the multidrug-resistance regulator RamR repressor from <italic>S.</italic> Typhimurium that enables detection of the benzylisoquinoline alkaloid (BIA) group of plant therapeutic alkaloids<sup><xref ref-type="bibr" rid="R43">43</xref></sup>. They engineered <italic>E. coli</italic> for heterologous expression of RamR and demonstrated the utility of this sensor as a tool to detect BIAs, including the anti-tumor alkaloid noscapine (NOS)<sup><xref ref-type="bibr" rid="R44">44</xref></sup> by incorporating its binding site into a synthetic promoter driving expression of a fluorescent reporter gene. <italic>Salmonella</italic> strain expressing genomic RamR under the control of its native promoter was engineered to harbor a synthetic promoter with the RamR BS driving sfGFP expression, termed SALSOR 0.1 (<xref ref-type="fig" rid="F6">Fig. 6a</xref>). Moreover, we engineered the SALSOR 0.2 strain, which, in addition to harboring the synthetic RamR-sfGFP reporter module, expresses chromosomally RamR encoded under the control of our above-developed arabinose-inducible JUB1-derived ATF in combination with synthetic promoter harboring four copies of JUB1 BS (<xref ref-type="fig" rid="F6">Fig. 6b</xref>). As shown in <xref ref-type="fig" rid="F6">Fig. 6c</xref>, the SALSOR 0.1 biosensor strain was able to detect NOS. Low background signals (in the absence of NOS) generally lead to an increased signal-to-noise ratio and thus a better detection (lower detection limit) of the ligand. Therefore, we reasoned that employing the arabinose-inducible JUB1-derived ATF would allow us to increase the expression levels of the RamR repressor. As expected, when using the SALSOR 0.2 biosensor, the background signal was reduced by 30% compared to the SALSOR 0.1 biosensor (<xref ref-type="fig" rid="F6">Fig. 6c</xref>).</p></sec><sec id="S8"><title>Arabinose-inducible, plant-derived ATF for β-carotene production in <italic>E. coli</italic></title><p id="P16">We next aimed to validate the capacity of plant-derived ATFs to activate transcription of large operons for metabolic engineering applications in Gram-negative bacteria. To this end, we chose to evaluate control of the well-characterized β-carotene biosynthesis pathway using plant-derived ATFs. In order to convert bacterial farnesyl pyrophosphate (FPP) precursor to β-carotene, geranylgeranyl diphosphate synthase (<italic>crtE</italic>), phytoene synthase (<italic>crtB</italic>), phytoene desaturase (<italic>crtI</italic>) and lycopene cyclase (<italic>crtY</italic>) enzymes are needed (<xref ref-type="fig" rid="F6">Fig. 6a</xref>). We first transformed <italic>E. coli</italic> with the episomal pK2151201 plasmid (constructed by Glasgow iGEM 2016, <xref ref-type="fig" rid="F6">Fig. 6b</xref>) harboring the <italic>crtEBIY</italic> genes in a single operon placed under control of the constitutive, strong promoter <italic>P<sub>J23106</sub></italic> (designed by J. Anderson, iGEM2006), and where each gene is placed downstream of an individual RBS. We next implemented a synthetic promoter containing five copies of the JUB1 TF binding site to control expression of the <italic>crtEBIY</italic> operon in pCAROTENE5X and integrated the arabinose-inducible JUB1-derived ATF into the <italic>att186</italic> site of <italic>E. coli.</italic> The episomal pK2151200 plasmid harboring the <italic>crtEBIY</italic> operon without a promoter (constructed by Glasgow iGEM 2016, <xref ref-type="fig" rid="F6">Fig. 6b</xref>) was used as control.</p><p id="P17">As shown in <xref ref-type="fig" rid="F6">Fig. 6c</xref>, the strain with ATF control modules produced ~1.9-fold more β-carotene than the control strain that harbored a promoter-less <italic>crtEBIY</italic> operon. Importantly, the β-carotene level was ~1.6-fold increased in the strain expressing the JUB1-derived ATF compared to the strain where a strong <italic>P<sub>J23106</sub></italic> promoter expressed the <italic>crtEBIY</italic> operon, suggesting that the JUB1- derived ATF has the capacity to increase transcription of the <italic>crtEBIY</italic> operon.</p></sec></sec><sec id="S9" sec-type="discussion"><title>Discussion</title><p id="P18">Gram-negative bacteria display biotechnological potential to serve as a platform for the production of hard-to-express proteins and might function as drug delivery system exploiting their large repertoire of protein secretion systems. However, a major problem preventing drug-carrying Gram-negative bacteria from being fully exploited in cancer therapy is the toxicity of the drugs to non-tumor tissues, resulting in damage to healthy tissues at the sites of initial localization of the bacteria (mainly the liver and spleen)<sup><xref ref-type="bibr" rid="R47">47</xref></sup>. Therefore, inducible systems allowing protein expression at the desired time are needed<sup><xref ref-type="bibr" rid="R48">48</xref></sup>. In addition, many Gram-negative bacteria harbor important virulence factors under the control of complex, poorly understood gene regulatory networks. In order to better understand the regulatory mechanisms of Gram-negative pathogenesis, but also to optimize them for bioengineering applications, species-specific orthogonal synthetic tools are required to enable inducible gene expression with a wide dynamic range. Yet, such tools are largely absent from the methodological toolbox currently used in prokaryotic synthetic biology research<sup><xref ref-type="bibr" rid="R49">49</xref>, <xref ref-type="bibr" rid="R50">50</xref>, <xref ref-type="bibr" rid="R51">51</xref></sup>.</p><p id="P19">It is preferable to use synthetic regulatory systems to induce target gene expression. In the past, a few native promoters of Gram-negative bacteria have been used to control expression of target genes. However, native bacterial promoters are under the control of endogenous bacterial TFs, which may interfere with endogenous regulatory networks of the host, making them suboptimal for synthetic biology applications. Furthermore, the most effective production strategy preferably combines a biomass growth phase followed by a protein-of-interest production phase. Using inducible regulators, the expression of regulators and any possible adverse interactions with the genome, metabolites, and proteins of the host that might result in undesirable fitness costs can be delayed until the optimal time of induction. In this study, we evaluated the usage of arabinose as an inducer of gene expression in <italic>Salmonella.</italic> As the availability of arabinose as a nutrient source plays a critical role in modulating <italic>P<sub>BAD</sub></italic>-controlled gene expression<sup><xref ref-type="bibr" rid="R32">32</xref></sup>, we first optimized the arabinose catabolic pathways by modifying the endogenous regulatory network. We next established arabinose-inducible, CRISPR/dCas9-derived ATFs to control gene expression in bacteria. We further evaluated several TF families from the plant <italic>A. thaliana</italic> (absent from prokaryotes) for their capacity to induce gene expression in bacteria. We developed and tested 18 and 11 arabinose-inducible ATFs derived from dCas9 and plant TFs in <italic>Salmonella</italic> (shown in <xref ref-type="fig" rid="F3">Fig. 3d</xref>, <xref ref-type="fig" rid="F4">Fig. 4c</xref> and d, and Fig. S5) and <italic>E. coli</italic> (shown in <xref ref-type="fig" rid="F4">Fig. 4a</xref> and <xref ref-type="supplementary-material" rid="SD13">Supplementary Fig. 3a</xref>), respectively. Here, we dissected the interplay between TF copy number (using plasmid- and chromosomal-based expressions), the number of its target binding sites, in wild-type background or optimized background (through rewiring the endogenous network allowing weak expression or deletion of the arabinose consuming pathway, <xref ref-type="fig" rid="F2">Fig. 2</xref>). We observed a broad spectrum of inducible transcriptional outputs that makes our collection of ATFs a suitable choice for synthetic biology applications in <italic>E. coli</italic> and <italic>Salmonella.</italic> We detected a high degree of regulator transferability from <italic>E. coli</italic><sup><xref ref-type="bibr" rid="R24">24</xref></sup> (<xref ref-type="supplementary-material" rid="SD13">Supplementary Fig. 3a</xref>) to <italic>Salmonella</italic> (<xref ref-type="fig" rid="F3">Fig. 3d</xref>) in case of the strong CRISPR/dCas9-derived ATF in combination with scRNA targeting J105 within a constitutive promoter. In other words, the strongest CRISPR/dCas9-derived ATF led to the highest gene expression, regardless of the host of choice, suggesting that other available regulatory tools for <italic>E. coli</italic><sup><xref ref-type="bibr" rid="R24">24</xref>, <xref ref-type="bibr" rid="R40">40</xref></sup> can be adapted to establish ATFs in <italic>Salmonella.</italic> Here, we also validated the transferability of terminators and promoters from <italic>E. coli</italic> to <italic>Salmonella,</italic> in addition to plant-derived ATFs and CRISPR/dCas9 ATFs from, respectively, plant and <italic>E. coli.</italic> To demonstrate a practical application of plant-derived ATFs, we studied β-carotene production in <italic>E. coli,</italic> where one of our developed ATF/BSs systems was employed to control gene expression of the β-carotene biosynthesis operon. An <italic>E. coli</italic> strain harboring the β-carotene biosynthesis operon under control of the plant-derived ATF, produced β-carotene to ~1.6-fold greater levels compared to a strain that expressed the β-carotene biosynthesis operon from a constitutive promoter. In fact, the metabolic burden raised from the constitutive expression of the pathway enzymes may cause more severe effects compared to the inducible plant-derived ATF expression system, allowing β-carotene production at a specific time point, by addition of arabinose (e.g. in the production phase), opening up a new door for applying plant-derived ATFs in prokaryotic microbial cell factories. We further demonstrated that plant-derived ATFs are a promising tool for establishing <italic>Salmonella</italic> as a sensitive biosensor detecting alkaloid NOS, by developing a biosensor strain termed SALSOR 0.2. The SALSOR 0.2 strain can be used for high-throughput screening of other alkaloid products in chemical engineering projects. The complete microbial biosynthesis of NOS has recently been reported<sup><xref ref-type="bibr" rid="R52">52</xref></sup>. Therefore, it might be one next valuable anticancer metabolite to be sustainably biomanufactured in microorganisms such as <italic>E. coli, Salmonella,</italic> and yeast. An interesting potential application of SALSOR 0.2 strain will be its application as the whole-cell biosensor for rapid quantification of the extracellular alkaloid concentration produced by other microbial cell factories<sup><xref ref-type="bibr" rid="R42">42</xref>, <xref ref-type="bibr" rid="R53">53</xref></sup>. In addition to NOS, SALSOR 0.2 might be utilized to detect other therapeutically relevant and commercially available RamR-interacting BIAs such as papaverine, rotundone and glaucine. Additionally, the plant-derived ATFs can be employed to establish other sensitive biosensors, such as CamR from <italic>Pseudomonas putida</italic> that is able to detect bicyclic monoterpenes alkaloids<sup><xref ref-type="bibr" rid="R54">54</xref></sup>.</p><p id="P20">In summary, we established a collection of arabinose-inducible ATF for tunable gene expression in <italic>Salmonella</italic> and <italic>E. coli</italic>, which can be potentially adapted for synthetic biology applications also in other Gram-negative bacteria, such as <italic>Pseudomonas aeruginosa</italic>. Another aspect for further improvement is the assessment of other ATFs derived from TFs of either plants or other heterologous organisms in <italic>Salmonella</italic> and <italic>E. coli</italic>. Further, our collection of arabinose-inducible ATFs allows for fine-tuning of gene expression via controlling the heterologous protein production and are therefore promising tools for rewiring gene regulatory networks of Gram-negative bacteria.</p></sec><sec id="S10" sec-type="methods"><title>Methods</title><sec id="S11"><title>General</title><p id="P21">Strains used in this study derive from <italic>S. enterica</italic> serovar Typhimurium strain LT2, <italic>E. coli</italic> DH10β (NEB, Frankfurt am Main, Germany) and <italic>E. coli</italic> DH10B-ALT (<italic>E. coli</italic> DH10B modified to constitutively express <italic>araC,</italic> Addgene, #61151) and are listed in <xref ref-type="supplementary-material" rid="SD10">Table S1</xref>. Plasmids were constructed using the NEBuilder HiFi DNA assembly strategy of New England Biolabs (NEB, Frankfurt am Main, Germany)<sup><xref ref-type="bibr" rid="R55">55</xref></sup>, or digestion and ligation using T4-DNA ligase (NEB, Frankfurt am Main, Germany). Plasmid and primer sequences are listed in <xref ref-type="supplementary-material" rid="SD11">Tables S2</xref> and <xref ref-type="supplementary-material" rid="SD11">S3</xref>, respectively. PCR amplification of DNA fragments was performed using high-fidelity polymerases: Q5 DNA Polymerase (New England Biolabs, Frankfurt am Main, Germany), Phusion Polymerase (Thermo Fisher Scientific) or PrimeSTAR GXL DNA Polymerase (Takara Bio, Saint-Germain-en-Laye, France) according to the manufacturers’ recommendations. All restriction enzymes were purchased from New England Biolabs (Frankfurt am Main, Germany). Amplified and digested DNA fragments were gel-purified prior to further use. Primers were ordered from IDT (Integrated DNA Technologies Inc., Dessau-Rosslau, Germany) and Sigma-Aldrich (Deisenhofen, Germany). All gBlocks were ordered from IDT (Dessau-Rosslau, Germany). Standard <italic>E. coli</italic> cloning strains were NEB dam<sup>-</sup>/dcm<sup>-</sup>, NEB 5α, or NEB 10β (New England Biolabs) were transformed by heat-shock to propagate constructed plasmids. Strains were grown in Luria-Bertani (LB) medium containing 10 g Tryptone, 5 g Yeast Extract, 5 g NaCl per liter and an appropriate antibiotic(s) (Ampicillin, 100 μg/ml; Chloramphenicol, 50 μg/ml; or Kanamycin, 50 μg/ml). The integrity of plasmid constructs was confirmed by sequencing (Microsynth Seqlab, Goettingen, Germany).</p><p id="P22">Plasmids or integration fragments were amplified by PCR, and, using λ red-mediated homologous recombination standard protocols, twere next integrated into the chromosome of <italic>S.</italic> Typhimurium LT2 (see <xref ref-type="supplementary-material" rid="SD9">Supplementary Method</xref>), or <italic>E. coli</italic> (NEB). Integrations into chromosomal <italic>attB</italic> sites of <italic>S.</italic> Typhimurium LT2 or <italic>E. coli</italic> DH10B-ALT target strains were performed as described by St-Pierre <italic>et al.</italic> (2013)<sup><xref ref-type="bibr" rid="R58">58</xref></sup>. DNAs were introduced by electroporation into the cells. For selecting chromosomal integrants, we used the appropriate antibiotic(s) (Ampicillin, 50 μg/ml; Chloramphenicol, 15 μg/ml; or/and Kanamycin, 25 μg/ml). When required, an appropriate concentration of arabinose (see <xref ref-type="sec" rid="S2">Results</xref>) was added. Single copy integration of each linearized fragment into the target chromosomal site was verified by colony PCR (and by sequencing). Methodologies to construct the plasmids and strains were described in <xref ref-type="supplementary-material" rid="SD9">Supplementary Methods.</xref></p></sec><sec id="S12"><title>Induction experiments</title><p id="P23">Single colonies of bacterial reporter strains were inoculated into 2 mL LB supplemented with appropriate antibiotics and grown at 37 °C (<italic>E. coli</italic>) or 30 °C (<italic>S.</italic> Typhimurium LT2), 220 RPM overnight. Late stationary phase cultures were diluted 1:100 in LB supplemented with appropriate antibiotic(s). For inducible system construction with <italic>P<sub>BAD</sub>,</italic> strains were inoculated in LB medium supplemented appropriate antibiotic(s) with arabinose at 0.0001%, 0.0005%, 0.001%, 0.005%, 0.01%, 0.05%, 0.1%, or 0.2% and cells were harvested at certain time point (see <xref ref-type="sec" rid="S2">Results</xref>).</p></sec><sec id="S13"><title>Plate reader experiments</title><p id="P24">Cells were inoculated in 2 mL LB supplemented with appropriate antibiotics for fluorescent reporter experiments and grown at 30 °C (<italic>S.</italic> Typhimurium), or 37 °C (<italic>E. coli</italic>), 220 RPM overnight. Overnight cultures were diluted 1:100 in fresh LB with appropriate antibiotic(s) (see <xref ref-type="supplementary-material" rid="SD9">“Supplementary Method”</xref>), and appropriate concentration of arabinose (see <xref ref-type="sec" rid="S2">Results</xref>) and 150 μL were aliquoted in triplicate flat, clear-bottomed 96-well black plates (Greiner Bio-one), closed with corning 96 well plates sterile lid and condensation rings (Greiner Bio-one), and grown with shaking at 30 °C (<italic>S.</italic> Typhimurium), or 37 °C (<italic>E. coli</italic>) in a Biotek Synergy H1 plate reader. OD<sub>600</sub> and mRFP1 fluorescence (excitation 510 ± 10 nm, emission 625 ± 20 nm), or OD<sub>600</sub> and sfGFP fluorescence (excitation 478 ± 10 nm, emission 515 ± 20 nm) were measured every 10 min. For ATF library characterization (<xref ref-type="fig" rid="F3">Fig. 3c</xref> and <xref ref-type="fig" rid="F4">Fig. 4d</xref>), the fluorescence measured after 210 min was divided by the average OD<sub>600</sub>.</p><p id="P25">For biosensor characterization in <italic>Salmonella</italic> strains, we adapted the protocol reported by d’Oelsnitz <italic>et al.</italic> (2022)<sup><xref ref-type="bibr" rid="R43">43</xref></sup> for biosensor characterization in <italic>E. coli.</italic> The cells were inoculated in 2 mL LB supplemented with appropriate antibiotics and grown at 30 °C, 220 RPM overnight. The following day, 20 μl of each culture was then used to inoculate six separate wells in a 2 mL 24 Deep Well RB Block (Thermo Scientific) closed with a Seal film (Thermo Scientific) containing 900 μl LB medium, one for test alkaloid ligand NOS and a solvent control. After 3.5 h of growth at 30 °C, cultures were induced with 100 μl LB medium containing either 10 μl DMSO or 100 μl LB medium containing the target alkaloid dissolved in 10 μl DMSO. The maximum NOS concentration of 100 μM was used due to the compound’s solubility limit in 1% DMSO. Cultures were grown for an additional 7 h at 37 °C and 250 RPM and subsequently centrifuged (3,500g, 4 °C, 10 min). The supernatant was removed, and cell pellets were resuspended in 1 ml PBS (137 mM NaCl, 2.7 mM KCl, 10 mM Na<sub>2</sub>HPO<sub>4</sub>, 1.8 mM KH<sub>2</sub>PO<sub>4</sub>, pH 7.4). 100 μL of the cell resuspension for each condition was transferred to a 96-well microtiter sterile black, clear bottom plate closed with 96-well lid (Greiner Bio-One) to perform plate reader experiment.</p></sec><sec id="S14"><title>Flow cytometry and data analysis</title><p id="P26">For fluorescent reporter experiments, cells were inoculated in 2 mL LB supplemented with appropriate antibiotics and grown at 30 °C, 220 RPM overnight. Overnight cultures were diluted 1:100 in fresh 2 mL LB with appropriate antibiotics (see <italic>“Construction of plasmids and strains”</italic>) and appropriate concentrations of arabinose (see <xref ref-type="sec" rid="S2">Results</xref>) and grown at 37 °C (<italic>S</italic>. Typhimurium), 220 RPM. After 210 min, cultures were then diluted 1:40 in PBS and analyzed using a SH800S cell sorter Flow Cytometer (Sony). sfGFP fluorescence values were obtained from a minimum of 10,000 cells in each sample. The mean GFP fluorescence per cell was calculated using FlowJo Software.</p><p id="P27">For optimization of the arabinose-based toolkit in <italic>Salmonella</italic> (<xref ref-type="fig" rid="F2">Fig. 2b</xref>), cells were inoculated in 2 mL LB supplemented. Ampicillin was added to the cultures for plasmid-based expression. The cultures were grown at 37 °C, 220 RPM overnight. Overnight cultures were diluted 1:100 in fresh 2 mL LB (Ampicillin for plasmid-based expression was used), and different concentrations of arabinose were added to the cultures and grown at 37 °C, 220 RPM for 150 min (chromosome-based expression) or 180 min (plasmid-based expression). Next, the OD<sub>600</sub> was measured and cells were fixed in a 4% paraformaldehyde (PFA) solution. Briefly, the cultures were centrifugated. The supernatants were discarded, and the pellets were resuspended in 500 μL of 4 % PFA. After incubation for at least 5 min at room temperature, the cells were washed with PBS before the flow cytometry analysis.</p></sec><sec id="S15"><title>β-Carotene production and quantification</title><p id="P28">The <italic>E. coli</italic> strains transformed with pK2151200, and pK2151201 plasmids were plated on LB, supplemented with chloramphenicol. The <italic>E. coli</italic> strains genetically modified at the <italic>att186</italic> site for arabinose-dependent induction of JUB1-derived ATF and transformed with pCAROTENE5X plasmid were plated on LB, supplemented with kanamycin and chloramphenicol. Cells were grown at 30 °C for 24 h. The colonies were inoculated into a 4 mL non-induction LB medium and grown overnight at 30°C and 200 RPM in a rotary shaker. A day after, the pre-cultures were used to inoculate main cultures (4 ml) in an induction medium (0.2% arabinose). All cultures were inoculated from pre-cultures to an initial OD<sub>600</sub> of 0.1. Cells were grown for 24 h at 30°C and 200 RPM to saturation.</p><p id="P29">Stationary phase bacterial cells were collected by centrifugation at 13,000×g for 1 min and, using the method reported by Lian <italic>et al.,</italic><sup><xref ref-type="bibr" rid="R46">46</xref></sup> β-carotene was assessed. Briefly, cell pellets were resuspended in 1 ml of 3 N HCl, boiled for 5 min, and cooled in an ice-bath for 5 min. Next, the lysed cells were washed with ddH<sub>2</sub>O and resuspended in 400 μl acetone to extract β-carotene. The cell debris were removed by centrifugation. The extraction step was repeated until the cell pellet appeared white. The β-carotene containing supernatant was analyzed for its absorbance at 450 nm (A<sub>450</sub>). The production of β-carotene was normalized to the cell density.</p></sec></sec><sec sec-type="supplementary-material" id="SM"><title>Supplementary Material</title><supplementary-material content-type="local-data" id="SD1"><label>Data S1</label><media xlink:href="EMS158002-supplement-Data_S1.xlsx" mimetype="application" mime-subtype="vnd.openxmlformats-officedocument.spreadsheetml.sheet" id="d2aAdEbB" position="anchor"/></supplementary-material><supplementary-material content-type="local-data" id="SD2"><label>Data S2</label><media xlink:href="EMS158002-supplement-Data_S2.xlsx" mimetype="application" mime-subtype="vnd.openxmlformats-officedocument.spreadsheetml.sheet" id="d2aAdEcB" position="anchor"/></supplementary-material><supplementary-material content-type="local-data" id="SD3"><label>Data S3</label><media xlink:href="EMS158002-supplement-Data_S3.xlsx" mimetype="application" mime-subtype="vnd.openxmlformats-officedocument.spreadsheetml.sheet" id="d2aAdEdB" position="anchor"/></supplementary-material><supplementary-material content-type="local-data" id="SD4"><label>Data S4</label><media xlink:href="EMS158002-supplement-Data_S4.xlsx" mimetype="application" mime-subtype="vnd.openxmlformats-officedocument.spreadsheetml.sheet" id="d2aAdEeB" position="anchor"/></supplementary-material><supplementary-material content-type="local-data" id="SD5"><label>Data S5</label><media xlink:href="EMS158002-supplement-Data_S5.xlsx" mimetype="application" mime-subtype="vnd.openxmlformats-officedocument.spreadsheetml.sheet" id="d2aAdEfB" position="anchor"/></supplementary-material><supplementary-material content-type="local-data" id="SD6"><label>Data S6</label><media xlink:href="EMS158002-supplement-Data_S6.xlsx" mimetype="application" mime-subtype="vnd.openxmlformats-officedocument.spreadsheetml.sheet" id="d2aAdEgB" position="anchor"/></supplementary-material><supplementary-material content-type="local-data" id="SD7"><label>Data S7</label><media xlink:href="EMS158002-supplement-Data_S7.xlsx" mimetype="application" mime-subtype="vnd.openxmlformats-officedocument.spreadsheetml.sheet" id="d2aAdEhB" position="anchor"/></supplementary-material><supplementary-material content-type="local-data" id="SD8"><label>Data S8</label><media xlink:href="EMS158002-supplement-Data_S8.xlsx" mimetype="application" mime-subtype="vnd.openxmlformats-officedocument.spreadsheetml.sheet" id="d2aAdEiB" position="anchor"/></supplementary-material><supplementary-material content-type="local-data" id="SD9"><label>Supplementary Methods</label><media xlink:href="EMS158002-supplement-Supplementary_Methods.pdf" mimetype="application" mime-subtype="pdf" id="d2aAdEjB" position="anchor"/></supplementary-material><supplementary-material content-type="local-data" id="SD10"><label>Supplementary Table S1</label><media xlink:href="EMS158002-supplement-Supplementary_Table_S1.xlsx" mimetype="application" mime-subtype="vnd.openxmlformats-officedocument.spreadsheetml.sheet" id="d2aAdEkB" position="anchor"/></supplementary-material><supplementary-material content-type="local-data" id="SD11"><label>Supplementary Table S2</label><media xlink:href="EMS158002-supplement-Supplementary_Table_S2.xlsx" mimetype="application" mime-subtype="vnd.openxmlformats-officedocument.spreadsheetml.sheet" id="d2aAdElB" position="anchor"/></supplementary-material><supplementary-material content-type="local-data" id="SD12"><label>Supplementary Table S3</label><media xlink:href="EMS158002-supplement-Supplementary_Table_S3.xlsx" mimetype="application" mime-subtype="vnd.openxmlformats-officedocument.spreadsheetml.sheet" id="d2aAdEmB" position="anchor"/></supplementary-material><supplementary-material content-type="local-data" id="SD13"><label>Supplementary Figures</label><media xlink:href="EMS158002-supplement-Supplementary_Figures.pdf" mimetype="application" mime-subtype="pdf" id="d2aAdEnB" position="anchor"/></supplementary-material></sec></body><back><ack id="S16"><title>Acknowledgments</title><p>We thank Sean Colloms (University of Glasgow) for providing the plasmids pK2151200 and pK2151201, and Kelly T. Hughes (University of Utah) for kindly providing the <italic>Salmonella</italic> strains TH437, TH3730 and TH6701. This work was supported in part by the European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation program (grant to M.E.; agreement no. 864971). E.C. (Max Planck Scientific Member) and M.E. (Max Planck Fellow) acknowledge the Max Planck Society for its support. E. C. also thanks the German Research Foundation (support through the Leibniz Prize).</p></ack><sec id="S17" sec-type="data-availability"><title>Data availability</title><p id="P30">The relevant data are available from the corresponding authors upon request.</p></sec><fn-group><fn id="FN1" fn-type="con"><p id="P31"><bold>Author contributions</bold></p><p id="P32">M.E. and G.N. conceived the study. G.N. designed experiments. H.R. designed arabinose induction experiments. G.N. analyzed the data with contribution from H.R.. G.N. and M.E. wrote the manuscript. E.C. and M.E contributed funding and resources. All authors proof-read and approved the manuscript.</p></fn><fn id="FN2" fn-type="conflict"><p id="P33"><bold>Competing interests</bold>: The authors declare no competing interests.</p></fn></fn-group><ref-list><ref id="R1"><label>1</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Upadhyaya</surname><given-names>NM</given-names></name><name><surname>Ellis</surname><given-names>JG</given-names></name><name><surname>Dodds</surname><given-names>PN</given-names></name></person-group><source>A bacterial Type III secretion-based delivery system for functional assays of fungal effectors in cereals</source><publisher-name>Humana Press</publisher-name><year>2014</year><pub-id pub-id-type="pmid">24643568</pub-id></element-citation></ref><ref id="R2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Widmaier</surname><given-names>DM</given-names></name><name><surname>Voigt</surname><given-names>CA</given-names></name></person-group><article-title>Quantification of the physiochemical constraints on the export of spider silk proteins by <italic>Salmonella</italic> type III secretion</article-title><source>Microb Cell Fact</source><year>2010</year><volume>9</volume><elocation-id>78</elocation-id><pub-id pub-id-type="pmcid">PMC2987917</pub-id><pub-id pub-id-type="pmid">20973967</pub-id><pub-id pub-id-type="doi">10.1186/1475-2859-9-78</pub-id></element-citation></ref><ref id="R3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Majander</surname><given-names>K</given-names></name><etal/></person-group><article-title>Extracellular secretion of polypeptides using a modified <italic>Escherichia coli</italic> flagellar secretion apparatus</article-title><source>Nat Biotechnol</source><year>2005</year><volume>23</volume><fpage>475</fpage><lpage>481</lpage><pub-id pub-id-type="pmid">15806100</pub-id></element-citation></ref><ref id="R4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nguyen</surname><given-names>VH</given-names></name><name><surname>Kim</surname><given-names>HS</given-names></name><name><surname>Ha</surname><given-names>JM</given-names></name><name><surname>Hong</surname><given-names>Y</given-names></name><name><surname>Choy</surname><given-names>HE</given-names></name><name><surname>Min</surname><given-names>JJ</given-names></name></person-group><article-title>Genetically engineered <italic>Salmonella</italic> Typhimurium as an imageable therapeutic probe for cancer</article-title><source>Cancer Res</source><year>2010</year><volume>70</volume><fpage>18</fpage><lpage>23</lpage><pub-id pub-id-type="pmid">20028866</pub-id></element-citation></ref><ref id="R5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Forbes</surname><given-names>NS</given-names></name></person-group><article-title>Engineering the perfect (bacterial) cancer therapy</article-title><source>Nat Rev Cancer</source><year>2010</year><volume>10</volume><fpage>785</fpage><lpage>794</lpage><pub-id pub-id-type="pmcid">PMC3756932</pub-id><pub-id pub-id-type="pmid">20944664</pub-id><pub-id pub-id-type="doi">10.1038/nrc2934</pub-id></element-citation></ref><ref id="R6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Felgner</surname><given-names>S</given-names></name><etal/></person-group><article-title>The immunogenic potential of bacterial flagella for <italic>Salmonella</italic>-mediated tumor therapy</article-title><source>Int J Cancer</source><year>2020</year><volume>147</volume><fpage>448</fpage><lpage>460</lpage><pub-id pub-id-type="pmid">31755108</pub-id></element-citation></ref><ref id="R7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yoon</surname><given-names>W</given-names></name><etal/></person-group><article-title>Application of genetically engineered <italic>Salmonella</italic> Typhimurium for interferon-gamma-induced therapy against melanoma</article-title><source>Eur J Cancer</source><year>2017</year><volume>70</volume><fpage>48</fpage><lpage>61</lpage><pub-id pub-id-type="pmid">27883926</pub-id></element-citation></ref><ref id="R8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kishimoto</surname><given-names>H</given-names></name><etal/></person-group><article-title>Tumor-selective, adenoviral-mediated GFP genetic labeling of human cancer in the live mouse reports future recurrence after resection</article-title><source>Cell Cycle</source><year>2011</year><volume>10</volume><fpage>2737</fpage><lpage>2741</lpage><pub-id pub-id-type="pmcid">PMC3219541</pub-id><pub-id pub-id-type="pmid">21785265</pub-id><pub-id pub-id-type="doi">10.4161/cc.10.16.16756</pub-id></element-citation></ref><ref id="R9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pawelek</surname><given-names>JM</given-names></name><name><surname>Low</surname><given-names>KB</given-names></name><name><surname>Bermudes</surname><given-names>D</given-names></name></person-group><article-title>Bacteria as tumour-targeting vectors</article-title><source>Lancet Oncol</source><year>2003</year><volume>4</volume><fpage>548</fpage><lpage>556</lpage><pub-id pub-id-type="pmid">12965276</pub-id></element-citation></ref><ref id="R10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hong</surname><given-names>H</given-names></name><etal/></person-group><article-title>Targeted deletion of the ara operon of <italic>Salmonella</italic> Typhimurium enhances L-arabinose accumulation and drives PBAD-promoted expression of anti-cancer toxins and imaging agents</article-title><source>Cell Cycle</source><year>2014</year><volume>13</volume><fpage>3112</fpage><lpage>3120</lpage><pub-id pub-id-type="pmcid">PMC4613543</pub-id><pub-id pub-id-type="pmid">25486570</pub-id><pub-id pub-id-type="doi">10.4161/15384101.2014.949527</pub-id></element-citation></ref><ref id="R11"><label>11</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Oliveira</surname><given-names>J</given-names></name><name><surname>Reygaert</surname><given-names>WC</given-names></name></person-group><source>Gram negative bacteria</source><publisher-loc>Treasure Island (FL)</publisher-loc><publisher-name>StatPearls Publishing</publisher-name><year>2021</year><pub-id pub-id-type="pmid">30855801</pub-id></element-citation></ref><ref id="R12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Byndloss</surname><given-names>MX</given-names></name><name><surname>Rivera-Chavez</surname><given-names>F</given-names></name><name><surname>Tsolis</surname><given-names>RM</given-names></name><name><surname>Baumler</surname><given-names>AJ</given-names></name></person-group><article-title>How bacterial pathogens use type III and type IV secretion systems to facilitate their transmission</article-title><source>Curr Opin Microbiol</source><year>2017</year><volume>35</volume><fpage>1</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">27621139</pub-id></element-citation></ref><ref id="R13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coburn</surname><given-names>B</given-names></name><name><surname>Sekirov</surname><given-names>I</given-names></name><name><surname>Finlay</surname><given-names>BB</given-names></name></person-group><article-title>Type III secretion systems and disease</article-title><source>Clin Microbiol Rev</source><year>2007</year><volume>20</volume><fpage>535</fpage><lpage>549</lpage><pub-id pub-id-type="pmcid">PMC2176049</pub-id><pub-id pub-id-type="pmid">17934073</pub-id><pub-id pub-id-type="doi">10.1128/CMR.00013-07</pub-id></element-citation></ref><ref id="R14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jahan</surname><given-names>F</given-names></name><name><surname>Chinni</surname><given-names>SV</given-names></name><name><surname>Samuggam</surname><given-names>S</given-names></name><name><surname>Reddy</surname><given-names>LV</given-names></name><name><surname>Solayappan</surname><given-names>M</given-names></name><name><surname>Su Yin</surname><given-names>L</given-names></name></person-group><article-title>The complex mechanism of the <italic>Salmonella typhi</italic> biofilm formation that facilitates pathogenicity: A review</article-title><source>Int J Mol Sci</source><year>2022</year><volume>23</volume><issue>23</issue><elocation-id>6462</elocation-id><pub-id pub-id-type="pmcid">PMC9223757</pub-id><pub-id pub-id-type="pmid">35742906</pub-id><pub-id pub-id-type="doi">10.3390/ijms23126462</pub-id></element-citation></ref><ref id="R15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Husing</surname><given-names>S</given-names></name><etal/></person-group><article-title>Control of membrane barrier during bacterial type-III protein secretion</article-title><source>Nat Commun</source><year>2021</year><volume>12</volume><elocation-id>3999</elocation-id><pub-id pub-id-type="pmcid">PMC8239009</pub-id><pub-id pub-id-type="pmid">34183670</pub-id><pub-id pub-id-type="doi">10.1038/s41467-021-24226-1</pub-id></element-citation></ref><ref id="R16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Macnab</surname><given-names>RM</given-names></name></person-group><article-title>How bacteria assemble flagella</article-title><source>Annu Rev Microbiol</source><year>2003</year><volume>57</volume><fpage>77</fpage><lpage>100</lpage><pub-id pub-id-type="pmid">12730325</pub-id></element-citation></ref><ref id="R17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pandelakis</surname><given-names>M</given-names></name><name><surname>Delgado</surname><given-names>E</given-names></name><name><surname>Ebrahimkhani</surname><given-names>MR</given-names></name></person-group><article-title>CRISPR-based synthetic transcription factors in vivo: The future of therapeutic cellular programming</article-title><source>Cell Syst</source><year>2020</year><volume>10</volume><fpage>1</fpage><lpage>14</lpage><pub-id pub-id-type="pmcid">PMC7175797</pub-id><pub-id pub-id-type="pmid">31972154</pub-id><pub-id pub-id-type="doi">10.1016/j.cels.2019.10.003</pub-id></element-citation></ref><ref id="R18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Naseri</surname><given-names>G</given-names></name><name><surname>Koffas</surname><given-names>MAG</given-names></name></person-group><article-title>Application of combinatorial optimization strategies in synthetic biology</article-title><source>Nat Commun</source><year>2020</year><volume>11</volume><elocation-id>2446</elocation-id><pub-id pub-id-type="pmcid">PMC7229011</pub-id><pub-id pub-id-type="pmid">32415065</pub-id><pub-id pub-id-type="doi">10.1038/s41467-020-16175-y</pub-id></element-citation></ref><ref id="R19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davis</surname><given-names>JH</given-names></name><name><surname>Rubin</surname><given-names>AJ</given-names></name><name><surname>Sauer</surname><given-names>RT</given-names></name></person-group><article-title>Design, construction and characterization of a set of insulated bacterial promoters</article-title><source>Nucleic Acids Res</source><year>2011</year><volume>39</volume><fpage>1131</fpage><lpage>1141</lpage><pub-id pub-id-type="pmcid">PMC3035448</pub-id><pub-id pub-id-type="pmid">20843779</pub-id><pub-id pub-id-type="doi">10.1093/nar/gkq810</pub-id></element-citation></ref><ref id="R20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cooper</surname><given-names>KG</given-names></name><name><surname>Chong</surname><given-names>A</given-names></name><name><surname>Starr</surname><given-names>T</given-names></name><name><surname>Finn</surname><given-names>CE</given-names></name><name><surname>Steele-Mortimer</surname><given-names>O</given-names></name></person-group><article-title>Predictable, tunable protein production in <italic>Salmonella</italic> for studying host-pathogen interactions</article-title><source>Front Cell Infect Microbiol</source><year>2017</year><volume>7</volume><elocation-id>475</elocation-id><pub-id pub-id-type="pmcid">PMC5696353</pub-id><pub-id pub-id-type="pmid">29201859</pub-id><pub-id pub-id-type="doi">10.3389/fcimb.2017.00475</pub-id></element-citation></ref><ref id="R21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Silva-Rocha</surname><given-names>R</given-names></name><name><surname>de Lorenzo</surname><given-names>V</given-names></name></person-group><article-title>Mining logic gates in prokaryotic transcriptional regulation networks</article-title><source>FEBS Lett</source><year>2008</year><volume>582</volume><fpage>1237</fpage><lpage>1244</lpage><pub-id pub-id-type="pmid">18275855</pub-id></element-citation></ref><ref id="R22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Naseri</surname><given-names>G</given-names></name><name><surname>Prause</surname><given-names>K</given-names></name><name><surname>Hamdo</surname><given-names>HH</given-names></name><name><surname>Arenz</surname><given-names>C</given-names></name></person-group><article-title>Artificial transcription factors for tuneable gene expression in <italic>Pichia pastons</italic></article-title><source>Front Bioeng Biotechnol</source><year>2021</year><volume>9</volume><elocation-id>676900</elocation-id><pub-id pub-id-type="pmcid">PMC8381338</pub-id><pub-id pub-id-type="pmid">34434924</pub-id><pub-id pub-id-type="doi">10.3389/fbioe.2021.676900</pub-id></element-citation></ref><ref id="R23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Naseri</surname><given-names>G</given-names></name><name><surname>Balazadeh</surname><given-names>S</given-names></name><name><surname>Machens</surname><given-names>F</given-names></name><name><surname>Kamranfar</surname><given-names>I</given-names></name><name><surname>Messerschmidt</surname><given-names>K</given-names></name><name><surname>Mueller-Roeber</surname><given-names>B</given-names></name></person-group><article-title>Plant-derived transcription factors for orthologous regulation of gene expression in the yeast <italic>Saccharomyces cerevisiae</italic></article-title><source>ACS Synth Biol</source><year>2017</year><volume>6</volume><fpage>1742</fpage><lpage>1756</lpage><pub-id pub-id-type="pmid">28531348</pub-id></element-citation></ref><ref id="R24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dong</surname><given-names>C</given-names></name><name><surname>Fontana</surname><given-names>J</given-names></name><name><surname>Patel</surname><given-names>A</given-names></name><name><surname>Carothers</surname><given-names>JM</given-names></name><name><surname>Zalatan</surname><given-names>JG</given-names></name></person-group><article-title>Synthetic CRISPR-Cas gene activators for transcriptional reprogramming in bacteria</article-title><source>Nat Commun</source><year>2018</year><volume>9</volume><elocation-id>2489</elocation-id><pub-id pub-id-type="pmcid">PMC6021436</pub-id><pub-id pub-id-type="pmid">29950558</pub-id><pub-id pub-id-type="doi">10.1038/s41467-018-04901-6</pub-id></element-citation></ref><ref id="R25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ho</surname><given-names>HI</given-names></name><name><surname>Fang</surname><given-names>JR</given-names></name><name><surname>Cheung</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>HH</given-names></name></person-group><article-title>Programmable CRISPR-Cas transcriptional activation in bacteria</article-title><source>Mol Syst Biol</source><year>2020</year><volume>16</volume><elocation-id>e9427</elocation-id><pub-id pub-id-type="pmcid">PMC7356669</pub-id><pub-id pub-id-type="pmid">32657546</pub-id><pub-id pub-id-type="doi">10.15252/msb.20199427</pub-id></element-citation></ref><ref id="R26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bikard</surname><given-names>D</given-names></name><name><surname>Jiang</surname><given-names>W</given-names></name><name><surname>Samai</surname><given-names>P</given-names></name><name><surname>Hochschild</surname><given-names>A</given-names></name><name><surname>Zhang</surname><given-names>F</given-names></name><name><surname>Marraffini</surname><given-names>LA</given-names></name></person-group><article-title>Programmable repression and activation of bacterial gene expression using an engineered CRISPR-Cas system</article-title><source>Nucleic Acids Res</source><year>2013</year><volume>41</volume><fpage>7429</fpage><lpage>7437</lpage><pub-id pub-id-type="pmcid">PMC3753641</pub-id><pub-id pub-id-type="pmid">23761437</pub-id><pub-id pub-id-type="doi">10.1093/nar/gkt520</pub-id></element-citation></ref><ref id="R27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Wan</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>B</given-names></name></person-group><article-title>Engineered CRISPRa enables programmable eukaryote-like gene activation in bacteria</article-title><source>Nat Commun</source><year>2019</year><volume>10</volume><elocation-id>3693</elocation-id><pub-id pub-id-type="pmcid">PMC6710252</pub-id><pub-id pub-id-type="pmid">31451697</pub-id><pub-id pub-id-type="doi">10.1038/s41467-019-11479-0</pub-id></element-citation></ref><ref id="R28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schilling</surname><given-names>C</given-names></name><name><surname>Koffas</surname><given-names>MAG</given-names></name><name><surname>Sieber</surname><given-names>V</given-names></name><name><surname>Schmid</surname><given-names>J</given-names></name></person-group><article-title>Novel prokaryotic CRISPR-Cas12a-based tool for programmable transcriptional activation and repression</article-title><source>ACS Synth Biol</source><year>2020</year><volume>9</volume><fpage>3353</fpage><lpage>3363</lpage><pub-id pub-id-type="pmid">33238093</pub-id></element-citation></ref><ref id="R29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Naseri</surname><given-names>G</given-names></name><name><surname>Behrend</surname><given-names>J</given-names></name><name><surname>Rieper</surname><given-names>L</given-names></name><name><surname>Mueller-Roeber</surname><given-names>B</given-names></name></person-group><article-title>COMPASS for rapid combinatorial optimization of biochemical pathways based on artificial transcription factors</article-title><source>Nat Commun</source><year>2019</year><volume>10</volume><elocation-id>2615</elocation-id><pub-id pub-id-type="pmcid">PMC6565718</pub-id><pub-id pub-id-type="pmid">31197154</pub-id><pub-id pub-id-type="doi">10.1038/s41467-019-10224-x</pub-id></element-citation></ref><ref id="R30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fritz</surname><given-names>G</given-names></name><etal/></person-group><article-title>Single cell kinetics of phenotypic switching in the arabinose utilization system of <italic>E. coli</italic></article-title><source>PLoS One</source><year>2014</year><volume>9</volume><elocation-id>e89532</elocation-id><pub-id pub-id-type="pmcid">PMC3935871</pub-id><pub-id pub-id-type="pmid">24586851</pub-id><pub-id pub-id-type="doi">10.1371/journal.pone.0089532</pub-id></element-citation></ref><ref id="R31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khlebnikov</surname><given-names>A</given-names></name><name><surname>Skaug</surname><given-names>T</given-names></name><name><surname>Keasling</surname><given-names>JD</given-names></name></person-group><article-title>Modulation of gene expression from the arabinose-inducible araBAD promoter</article-title><source>J Ind Microbiol Biotechnol</source><year>2002</year><volume>29</volume><fpage>34</fpage><lpage>37</lpage><pub-id pub-id-type="pmid">12080425</pub-id></element-citation></ref><ref id="R32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vasicek</surname><given-names>EM</given-names></name><name><surname>O’Neal</surname><given-names>L</given-names></name><name><surname>Parsek</surname><given-names>MR</given-names></name><name><surname>Fitch</surname><given-names>J</given-names></name><name><surname>White</surname><given-names>P</given-names></name><name><surname>Gunn</surname><given-names>JS</given-names></name></person-group><article-title>L-arabinose transport and metabolism in <italic>Salmonella</italic> influences biofilm formation</article-title><source>Front Cell Infect Microbiol</source><year>2021</year><volume>11</volume><elocation-id>698146</elocation-id><pub-id pub-id-type="pmcid">PMC8341724</pub-id><pub-id pub-id-type="pmid">34368016</pub-id><pub-id pub-id-type="doi">10.3389/fcimb.2021.698146</pub-id></element-citation></ref><ref id="R33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schleif</surname><given-names>R</given-names></name></person-group><article-title>AraC protein, regulation of the l-arabinose operon in <italic>Escherichia coli,</italic> and the light switch mechanism of AraC action</article-title><source>FEMS Microbiol Rev</source><year>2010</year><volume>34</volume><fpage>779</fpage><lpage>796</lpage><pub-id pub-id-type="pmid">20491933</pub-id></element-citation></ref><ref id="R34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simon</surname><given-names>LD</given-names></name><name><surname>Ann</surname><given-names>H</given-names></name></person-group><article-title>Conversion of the omega-subunit of <italic>Escherichia coli</italic> RNA polymerase into a transcriptional activator or an activation target</article-title><source>Genes &amp; Development</source><year>1998</year><volume>12</volume><fpage>745</fpage><lpage>754</lpage><pub-id pub-id-type="pmcid">PMC316573</pub-id><pub-id pub-id-type="pmid">9499408</pub-id><pub-id pub-id-type="doi">10.1101/gad.12.5.745</pub-id></element-citation></ref><ref id="R35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koita</surname><given-names>K</given-names></name><name><surname>Rao</surname><given-names>CV</given-names></name></person-group><article-title>Identification and analysis of the putative pentose sugar efflux transporters in Escherichia coli</article-title><source>PLoS One</source><year>2012</year><volume>7</volume><elocation-id>e43700</elocation-id><pub-id pub-id-type="pmcid">PMC3429515</pub-id><pub-id pub-id-type="pmid">22952739</pub-id><pub-id pub-id-type="doi">10.1371/journal.pone.0043700</pub-id></element-citation></ref><ref id="R36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jar-How</surname><given-names>L</given-names></name><name><surname>Robert</surname><given-names>JR</given-names></name><name><surname>Laurel</surname><given-names>H</given-names></name><name><surname>Gary</surname><given-names>W</given-names></name></person-group><article-title>Regulation of l-arabinose transport in <italic>Salmonella</italic> Typhimurium LT2</article-title><source>Mol Genet</source><year>1982</year><volume>185</volume><issue>136</issue><fpage>114</fpage><pub-id pub-id-type="pmid">6283309</pub-id></element-citation></ref><ref id="R37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Madar</surname><given-names>D</given-names></name><name><surname>Dekel</surname><given-names>E</given-names></name><name><surname>Bren</surname><given-names>A</given-names></name><name><surname>Alon</surname><given-names>U</given-names></name></person-group><article-title>Negative auto-regulation increases the input dynamic-range of the arabinose system of <italic>Escherichia coli</italic></article-title><source>BMC Syst Biol</source><year>2011</year><volume>5</volume><elocation-id>111</elocation-id><pub-id pub-id-type="pmcid">PMC3163201</pub-id><pub-id pub-id-type="pmid">21749723</pub-id><pub-id pub-id-type="doi">10.1186/1752-0509-5-111</pub-id></element-citation></ref><ref id="R38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yan</surname><given-names>Q</given-names></name><name><surname>Fong</surname><given-names>SS</given-names></name></person-group><article-title>Study of in vitro transcriptional binding effects and noise using constitutive promoters combined with UP element sequences in <italic>Escherichia coli</italic></article-title><source>J Biol Eng</source><year>2017</year><volume>11</volume><elocation-id>33</elocation-id><pub-id pub-id-type="pmcid">PMC5664571</pub-id><pub-id pub-id-type="pmid">29118850</pub-id><pub-id pub-id-type="doi">10.1186/s13036-017-0075-2</pub-id></element-citation></ref><ref id="R39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>St-Pierre</surname><given-names>F</given-names></name><name><surname>Cui</surname><given-names>L</given-names></name><name><surname>Priest</surname><given-names>DG</given-names></name><name><surname>Endy</surname><given-names>D</given-names></name><name><surname>Dodd</surname><given-names>IB</given-names></name><name><surname>Shearwin</surname><given-names>KE</given-names></name></person-group><article-title>One-step cloning and chromosomal integration of DNA</article-title><source>ACS Synth Biol</source><year>2013</year><volume>2</volume><fpage>537</fpage><lpage>541</lpage><pub-id pub-id-type="pmid">24050148</pub-id></element-citation></ref><ref id="R40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>MacDonald</surname><given-names>IC</given-names></name><name><surname>Seamons</surname><given-names>TR</given-names></name><name><surname>Emmons</surname><given-names>JC</given-names></name><name><surname>Javdan</surname><given-names>SB</given-names></name><name><surname>Deans</surname><given-names>TL</given-names></name></person-group><article-title>Enhanced regulation of prokaryotic gene expression by a eukaryotic transcriptional activator</article-title><source>Nat Commun</source><year>2021</year><volume>12</volume><elocation-id>4109</elocation-id><pub-id pub-id-type="pmcid">PMC8257575</pub-id><pub-id pub-id-type="pmid">34226549</pub-id><pub-id pub-id-type="doi">10.1038/s41467-021-24434-9</pub-id></element-citation></ref><ref id="R41"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamasaki</surname><given-names>K</given-names></name><name><surname>Kigawa</surname><given-names>T</given-names></name><name><surname>Seki</surname><given-names>M</given-names></name><name><surname>Shinozaki</surname><given-names>K</given-names></name><name><surname>Yokoyama</surname><given-names>S</given-names></name></person-group><article-title>DNA-binding domains of plant-specific transcription factors: structure, function, and evolution</article-title><source>Trends Plant Sci</source><year>2013</year><volume>18</volume><fpage>267</fpage><lpage>276</lpage><pub-id pub-id-type="pmid">23040085</pub-id></element-citation></ref><ref id="R42"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>J</given-names></name><etal/></person-group><article-title>A microbial supply chain for production of the anti-cancer drug vinblastine</article-title><source>Nature</source><year>2022</year><volume>609</volume><fpage>341</fpage><lpage>347</lpage><pub-id pub-id-type="pmcid">PMC9452304</pub-id><pub-id pub-id-type="pmid">36045295</pub-id><pub-id pub-id-type="doi">10.1038/s41586-022-05157-3</pub-id></element-citation></ref><ref id="R43"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>d’Oelsnitz</surname><given-names>S</given-names></name><etal/></person-group><article-title>Using fungible biosensors to evolve improved alkaloid biosyntheses</article-title><source>Nat Chem Biol</source><year>2022</year><volume>18</volume><fpage>981</fpage><lpage>989</lpage><pub-id pub-id-type="pmid">35799063</pub-id></element-citation></ref><ref id="R44"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rahmanian-Devin</surname><given-names>P</given-names></name><name><surname>Baradaran Rahimi</surname><given-names>V</given-names></name><name><surname>Jaafari</surname><given-names>MR</given-names></name><name><surname>Golmohammadzadeh</surname><given-names>S</given-names></name><name><surname>Sanei-Far</surname><given-names>Z</given-names></name><name><surname>Askari</surname><given-names>VR</given-names></name></person-group><article-title>Noscapine, an emerging medication for different diseases: A mechanistic review</article-title><source>Evid Based Complement Alternat Med</source><year>2021</year><elocation-id>8402517</elocation-id><pub-id pub-id-type="pmcid">PMC8648453</pub-id><pub-id pub-id-type="pmid">34880922</pub-id><pub-id pub-id-type="doi">10.1155/2021/8402517</pub-id></element-citation></ref><ref id="R45"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clifton</surname><given-names>KP</given-names></name><etal/></person-group><article-title>The genetic insulator RiboJ increases expression of insulated genes</article-title><source>J Biol Eng</source><year>2018</year><volume>12</volume><elocation-id>23</elocation-id><pub-id pub-id-type="pmcid">PMC6206723</pub-id><pub-id pub-id-type="pmid">30386425</pub-id><pub-id pub-id-type="doi">10.1186/s13036-018-0115-6</pub-id></element-citation></ref><ref id="R46"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lian</surname><given-names>J</given-names></name><name><surname>HamediRad</surname><given-names>M</given-names></name><name><surname>Hu</surname><given-names>S</given-names></name><name><surname>Zhao</surname><given-names>H</given-names></name></person-group><article-title>Combinatorial metabolic engineering using an orthogonal tri-functional CRISPR system</article-title><source>Nat Commun</source><year>2017</year><volume>8</volume><elocation-id>1688</elocation-id><pub-id pub-id-type="pmcid">PMC5700065</pub-id><pub-id pub-id-type="pmid">29167442</pub-id><pub-id pub-id-type="doi">10.1038/s41467-017-01695-x</pub-id></element-citation></ref><ref id="R47"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Min</surname><given-names>JJ</given-names></name><etal/></person-group><article-title>Noninvasive real-time imaging of tumors and metastases using tumor-targeting lightemitting Escherichia coli</article-title><source>Mol Imaging Biol</source><year>2008</year><volume>10</volume><fpage>54</fpage><lpage>61</lpage><pub-id pub-id-type="pmid">17994265</pub-id></element-citation></ref><ref id="R48"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bai</surname><given-names>F</given-names></name><name><surname>Li</surname><given-names>Z</given-names></name><name><surname>Umezawa</surname><given-names>A</given-names></name><name><surname>Terada</surname><given-names>N</given-names></name><name><surname>Jin</surname><given-names>S</given-names></name></person-group><article-title>Bacterial type III secretion system as a protein delivery tool for a broad range of biomedical applications</article-title><source>Biotechnol Adv</source><year>2018</year><volume>36</volume><fpage>482</fpage><lpage>493</lpage><pub-id pub-id-type="pmcid">PMC7145356</pub-id><pub-id pub-id-type="pmid">29409784</pub-id><pub-id pub-id-type="doi">10.1016/j.biotechadv.2018.01.016</pub-id></element-citation></ref><ref id="R49"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cooper</surname><given-names>KG</given-names></name><etal/></person-group><article-title>Regulatory protein HilD stimulates <italic>Salmonella</italic> Typhimurium invasiveness by promoting smooth swimming via the methyl-accepting chemotaxis protein McpC</article-title><source>Nat Commun</source><year>2021</year><volume>12</volume><elocation-id>348</elocation-id><pub-id pub-id-type="pmcid">PMC7806825</pub-id><pub-id pub-id-type="pmid">33441540</pub-id><pub-id pub-id-type="doi">10.1038/s41467-020-20558-6</pub-id></element-citation></ref><ref id="R50"><label>50</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hyun</surname><given-names>J</given-names></name><etal/></person-group><article-title>Engineered Attenuated <italic>Salmonella</italic> Typhimurium expressing neoantigen has anticancer effects</article-title><source>ACS Synth Biol</source><year>2021</year><volume>10</volume><fpage>2478</fpage><lpage>2487</lpage><pub-id pub-id-type="pmid">34525796</pub-id></element-citation></ref><ref id="R51"><label>51</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prindle</surname><given-names>A</given-names></name><etal/></person-group><article-title>Genetic Circuits in <italic>Salmonella</italic> Typhimurium</article-title><source>ACS Synth Biol</source><year>2012</year><volume>1</volume><fpage>458</fpage><lpage>464</lpage><pub-id pub-id-type="pmcid">PMC3477097</pub-id><pub-id pub-id-type="pmid">23097749</pub-id><pub-id pub-id-type="doi">10.1021/sb300060e</pub-id></element-citation></ref><ref id="R52"><label>52</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>S</given-names></name><name><surname>Thodey</surname><given-names>K</given-names></name><name><surname>Trenchard</surname><given-names>I</given-names></name><name><surname>Cravens</surname><given-names>A</given-names></name><name><surname>Smolke</surname><given-names>CD</given-names></name></person-group><article-title>Complete biosynthesis of noscapine and halogenated alkaloids in yeast</article-title><source>Proc Natl Acad Sci U S A</source><year>2018</year><volume>115</volume><fpage>3922</fpage><lpage>3931</lpage><pub-id pub-id-type="pmcid">PMC5924921</pub-id><pub-id pub-id-type="pmid">29610307</pub-id><pub-id pub-id-type="doi">10.1073/pnas.1721469115</pub-id></element-citation></ref><ref id="R53"><label>53</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Siedler</surname><given-names>S</given-names></name><name><surname>Stahlhut</surname><given-names>SG</given-names></name><name><surname>Malla</surname><given-names>S</given-names></name><name><surname>Maury</surname><given-names>J</given-names></name><name><surname>Neves</surname><given-names>AR</given-names></name></person-group><article-title>Novel biosensors based on flavonoid-responsive transcriptional regulators introduced into <italic>Escherichia coli</italic></article-title><source>Metab Eng</source><year>2014</year><volume>21</volume><fpage>2</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">24188962</pub-id></element-citation></ref><ref id="R54"><label>54</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>d’Oelsnitz</surname><given-names>S</given-names></name><name><surname>Nguyen</surname><given-names>V</given-names></name><name><surname>Alper</surname><given-names>HS</given-names></name><name><surname>Ellington</surname><given-names>AD</given-names></name></person-group><article-title>Evolving a generalist biosensor for bicyclic monoterpenes</article-title><source>ACS Synth Biol</source><year>2022</year><volume>11</volume><fpage>265</fpage><lpage>272</lpage><pub-id pub-id-type="pmid">34985281</pub-id></element-citation></ref><ref id="R55"><label>55</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Werling</surname><given-names>U</given-names></name><name><surname>Edelmann</surname><given-names>W</given-names></name></person-group><article-title>SLiCE: a novel bacterial cell extract-based DNA cloning method</article-title><source>Nucleic Acids Res</source><year>2012</year><volume>40</volume><fpage>e55</fpage><pub-id pub-id-type="pmcid">PMC3333860</pub-id><pub-id pub-id-type="pmid">22241772</pub-id><pub-id pub-id-type="doi">10.1093/nar/gkr1288</pub-id></element-citation></ref><ref id="R56"><label>56</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karlinsey</surname><given-names>JE</given-names></name></person-group><article-title>λ-Red Genetic Engineering in <italic>Salmonella enterica</italic> serovar Typhimurium</article-title><source>Advanced Bacterial Genetics (Use of Transposons and Phage for Genomic Engineering)</source><year>2007</year><pub-id pub-id-type="pmid">17352924</pub-id></element-citation></ref><ref id="R57"><label>57</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoffmann</surname><given-names>S</given-names></name><name><surname>Schmidt</surname><given-names>C</given-names></name><name><surname>Walter</surname><given-names>S</given-names></name><name><surname>Bender</surname><given-names>JK</given-names></name><name><surname>Gerlach</surname><given-names>RG</given-names></name></person-group><article-title>Scarless deletion of up to seven methyl-accepting chemotaxis genes with an optimized method highlights key function of CheM in <italic>Salmonella</italic> Typhimurium</article-title><source>PLoS One</source><year>2017</year><volume>12</volume><elocation-id>e0172630</elocation-id><pub-id pub-id-type="pmcid">PMC5315404</pub-id><pub-id pub-id-type="pmid">28212413</pub-id><pub-id pub-id-type="doi">10.1371/journal.pone.0172630</pub-id></element-citation></ref><ref id="R58"><label>58</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>St-Pierre</surname><given-names>F</given-names></name><name><surname>Cui</surname><given-names>L</given-names></name><name><surname>Priest</surname><given-names>DG</given-names></name><name><surname>Endy</surname><given-names>D</given-names></name><name><surname>Dodd</surname><given-names>IB</given-names></name><name><surname>Shearwin</surname><given-names>KE</given-names></name></person-group><article-title>One-step cloning and chromosomal integration of DNA</article-title><source>ACS Synth Biol</source><year>2013</year><volume>2</volume><fpage>537</fpage><lpage>541</lpage></element-citation></ref></ref-list></back><floats-group><fig id="F1" position="float"><label>Fig. 1</label><caption><title>Principle of arabinose-inducible ATFs established in this study.</title><p><bold>a</bold> Inducer-OFF state: In the absence of arabinose, AraC dimer binds to <italic>O<sub>2</sub></italic> and <italic>I<sub>1</sub></italic> half-sites, causing DNA looping, which prevents RNAP from accessing the promoter. As a result, the ATF is not expressed. Therefore, the expression of FP that is controlled by BS of ATF is prevented. <bold>b</bold> Inducer-ON state: Following the addition of arabinose, it enters the cell by a transporter. Arabinose-bound AraC dimer changes configuration and binds <italic>I<sub>1</sub></italic> and <italic>I<sub>2</sub></italic> half-sites of <italic>P<sub>BAD</sub>,</italic> activating the transcription of the ATF. The ATF targets its BS within a synthetic promoter, controlling FP expression. The interaction of the ATF and RNAP leads to increased FP transcription from the synthetic promoter compared to the OFF state<sup><xref ref-type="bibr" rid="R34">34</xref></sup>. To simplify the figure, the RBSs and terminators located, respectively, upstream and downstream of ATF and FP are not shown. Abbreviations: ATF, artificial transcription factor; BS, binding site; FP, fluorescent protein; <italic>I<sub>1</sub>, I<sub>2</sub></italic> and <italic>O<sub>2</sub></italic> represent DNA binding half-sites. <italic>GOI,</italic> gene of interest; <italic>P<sub>BAD</sub>,</italic> arabinose-inducible <italic>araBAD</italic> promoter; <italic>P<sub>min</sub>,</italic> minimal synthetic promoter containing the –35 and –10 regions of the essential elements; <italic>P<sub>weak</sub>,</italic> weak promoter; RNAP, RNA polymerase.</p></caption><graphic xlink:href="EMS158002-f001"/></fig><fig id="F2" position="float"><label>Fig. 2</label><caption><title>Optimization of the arabinose-based toolkit in <italic>Salmonella.</italic></title><p><bold>a.</bold> Regulatory network of the native arabinose utilization system in <italic>S.</italic> Typhimurium<sup><xref ref-type="bibr" rid="R32">32</xref></sup>, including the reporter cassette used in this study. The system consists of <italic>araE,</italic> encoding the arabinose transporter AraE essential for arabinose uptake, the <italic>araBAD</italic> operon, encoding enzymes for arabinose metabolism, and the regulator AraC-encoding gene. High amounts of intracellular arabinose activate <italic>araC</italic> expression, which stimulates expression from the promoters <italic>P<sub>BAD</sub></italic> and <italic>P<sub>araE</sub></italic> (in the absence of arabinose, AraC represses <italic>P<sub>BAD</sub></italic>-derived expression). Indicated in white shading are the mutants characterized in this study: deletion of the <italic>araBAD</italic> operon and constitutive <italic>araE</italic> expression at different levels. As a reporter, either plasmid- or chromosomal-based GFP expression system under the control of <italic>P<sub>BAD</sub></italic> was used. To simplify the figure, the possible negative feedback of AraC is not shown, as it mainly contributes to provide a constant AraC level<sup><xref ref-type="bibr" rid="R37">37</xref></sup>. Characterizing dose-dependency of arabinose-based gene expression from plasmid (<bold>b</bold>) or chromosome (<bold>c</bold>) in <italic>S.</italic> Typhimurium LT2. Light grey, wild-type; dark grey, <italic>araBAD</italic> deletion mutant; light red, mutant with decoupled arabinose-dependent transporter–reporter system; dark red, mutant with <italic>araBAD</italic> deletion and decoupled arabinose-dependent transporter-reporter system. As a reporter, sfGFP under the control of the <italic>P<sub>BAD</sub></italic> promoter, encoded on a plasmid (pBAD24-sfGFP) or in the chromosome (<italic>ΔaraBAD::sfGFP</italic>), was used. sfGFP-expression was measured by flow cytometry in presence of 0.00001%, 0.00005%, 0.0001%, 0.0005%, 0.001%, 0.005%, 0.01%, 0.05%, 0.1%, and 0.2% arabinose. The ‘induction window’ is highlighted in blue. Growth-curves of strains mutated for (<bold>d</bold>) arabinose-independent expression of the transporter and (<bold>e</bold>) arabinose-independent expression of transporter and deleted arabinose catabolism system in the presence of 0.2% arabinose in <italic>S.</italic> Typhimurium LT2 background. The growth of cells expressing <italic>araE</italic> from the weak <italic>P<sub>proA</sub></italic> (light red)<sup><xref ref-type="bibr" rid="R20">20</xref></sup> or strong <italic>P<sub>proD</sub></italic> (light orange)<sup><xref ref-type="bibr" rid="R20">20</xref></sup> constitutive promoters was compared with that of cells with arabinosedependent (araE) expression from the native <italic>P<sub>araE</sub></italic> in cells with or without deleted <italic>araBAD</italic> operon. Data are the average of three biological replicates. Abbreviations: a.u., arbitrary units; MFI, mean fluorescent intensity; <italic>P<sub>BAD</sub>,</italic> arabinose-responsive promoter; OD<sub>600</sub>, optical intensity at 600 nm; R<sup>2</sup>, the statistical measure of regression predictions in Goodness of Fit test; sfGFP, super-fold green fluorescent protein; X and Y, parameters of the linear regression equation. The full data are shown in <xref ref-type="supplementary-material" rid="SD1">Data S1</xref>.</p></caption><graphic xlink:href="EMS158002-f002"/></fig><fig id="F3" position="float"><label>Fig. 3</label><caption><title>Arabinose-inducible CRISPR/dCas9-derived ATF library for tunable gene expression in <italic>Salmonella</italic>.</title><p><bold>a</bold> Schematics showing CRISPR/dCas9-derived ATFs developed in the present study. The driver cassette (top) of CRISPR/dCas9-derived ATFs comprises i) DBD cassette containing a <italic>P<sub>BAD</sub></italic> at the 5’ end and <italic>S. pyogenes</italic> dCas9 (codon-optimized for expression in <italic>S.</italic> Typhimurium LT2 (dCas9 opt)), ii) scRNA cassette, encoding the crRNA and MS2 RNA hairpins under control of the constitutive <italic>P<sub>BBa-J23119</sub></italic><sup><xref ref-type="bibr" rid="R38">38</xref></sup>, and iii) AD cassette encoding MCP fused to SoxS(R93A) AD (codon-optimized for expression in <italic>S.</italic> Typhimurium LT2) via 5aa-linker under control of PBAD. In the presence of arabinose, dCas9 and SoxS are expressed. SoxS AD is recruited by MCP to the dCas9-scRNA complex via the MS2 RNA hairpin. The expressed driver targets a <italic>J1</italic>-derived synthetic promoter placed upstream of the gene of interest in the reporter cassette (bottom) via (a sequence in the) scRNA. The <italic>J1</italic>-derived synthetic promoter has potential crRNA target sites upstream of a weak P<sub>BBa_J23117</sub><sup><xref ref-type="bibr" rid="R24">24</xref></sup>. The schematics shows the condition in which the <italic>J1</italic>-derived synthetic promoter harbors two copies of ATF BS, located between -165 and -40 (to TSS). The interaction of the ATF and RNAP induces the transcription of <italic>mRFP1</italic><sup><xref ref-type="bibr" rid="R34">34</xref></sup>. Growth curve (<bold>b</bold>) and time course of mRFP1 expression level (<bold>c</bold>) in cells expressing the CRISPR/dCas9-derived ATF targeting J105 in <italic>S.</italic> Typhimurium LT2 background. Cells harbor chromosomally-integrated dCas9, plasmid-encoded MCP-linker-<underline>S</underline>oxS(R93A), J<underline>105</underline>-targeting scRNA and <italic><underline>J</underline>1</italic>-derived synthetic promoter to control mRFP1 expression. Light color, non-inducing medium (arabinose<sup>-</sup>); dark color, inducing medium (arabinose<sup>+</sup>). The statistically significant difference in expression for cells expressing CRISPR/dCas9-derived ATF targeting J105 under inducing medium (dark orange) compared to non-inducing medium (light orange) is shown in <xref ref-type="supplementary-material" rid="SD2">Data S2</xref>. <bold>d</bold> Library of arabinose-inducible, CRISPR/Cas9-derived ATFs in <italic>Salmonella.</italic> Fluorescence output was measured in the non-inducing medium (grey) and inducing medium (red). Data are expressed as the mean ± SD of the RFU obtained from three biological replicates, normalized to the OD<sub>600</sub>. Asterisks indicate a statistically significant difference from the non-inducing medium (two-sided <italic>t</italic>-test; *p ≤ 0.05, *** <italic>p</italic> ≤ 0.001). For induction, 0.05% arabinose was used. Abbreviations: aa, amino acid; AD, activation domain; a. u., arbitrary units; ATF, artificial transcription factor; BS, binding site; DBD, DNA binding domain; dCas9, catalytically inactive Cas9; gRNA, guide RNA; MCP, MS2 coating protein; mRFP1, monomeric red fluorescent protein 1; OD<sub>600</sub>, optical density at 600 nm; RFU, relative fluorescence units; scRNA, scaffold RNA; RNAP, RNA polymerase. The full data are shown in <xref ref-type="supplementary-material" rid="SD2">Data S2</xref>.</p></caption><graphic xlink:href="EMS158002-f003"/></fig><fig id="F4" position="float"><label>Fig. 4</label><caption><title>Arabinose-inducible, plant-derived ATFs for tunable gene expression in Gram-negative bacteria.</title><p><bold>a</bold> Schematics showing plant-derived ATFs developed in the present study. The driver cassette contains a <italic>P<sub>BAD</sub></italic> at the 5' end controlling expression of a plant TF fused via 5 aa-linker to SoxS(R93A) activation domain. In the presence of arabinose, the expressed ATF binds a <italic>J1</italic>-derived synthetic promoter upstream of <italic>P<sub>BBa_J23117</sub></italic> promoter<sup><xref ref-type="bibr" rid="R24">24</xref></sup>. In the schematics a reporter cassette with a synthetic promoter harboring two copies of TF-BS located between -165 and -40 (to TSS) is shown as example. Interaction between the ATF and RNAP drives reporter sfGFP expression<sup><xref ref-type="bibr" rid="R34">34</xref></sup>. <bold>b</bold> Arabinose-inducible, JUB1-derived ATFs encoded on a plasmid or in the chromosome in <italic>E. coli</italic>. Full-length plant JUB1 or only its DBD was chromosomally integrated at the <italic>att186</italic> site (dark green), or expression plasmids harboring full-length plant JUB1 or only its DBD were introduced into cell by transformation (light green). The ATF transactivation capacity in combination with two copies of BS was tested in inducing medium. The strains harboring driver cassette, but no reporter cassette were used as a negative control. <bold>c</bold> Arabinose-inducible, JUB1-derived ATF in <italic>Salmonella.</italic> The transactivation capacity of JUB1-derived ATFs in combination with the one, two, four, five or six copies of BS was tested in wild-type background. Grey, non-inducing medium; green, inducing medium; Constitutive promoter <italic>P<sub>prsM</sub>,</italic> positive control; JUB1-0x, negative control. <bold>d</bold> Optimization of arabinose-inducible, JUB1-derived ATFs toolkit in <italic>Salmonella.</italic> The transactivation capacity of the JUB1-derived ATF in combination with two or four copies of BS was tested in strain with deleted <italic>araBAD</italic> and constitutively expressing <italic>araE</italic> (from <italic>P<sub>proA</sub></italic>) (see <xref ref-type="fig" rid="F2">Fig. 2</xref>) (dark yellow) and wild-type background (green) in inducing medium. Data are expressed as the mean ± SD of the MFI (b, c) or RFU (d) obtained from three biological replicates. Asterisks indicate a statistically significant difference (<italic>t</italic>-test; ns, not significant; *<italic>p</italic> ≤ 0.05; **<italic>p</italic> ≤ 0.01; ***<italic>p</italic> ≤ 0.001). To simplify the figure, ribosome binding site and terminator are not shown. For induction, 0.2% and 0.05% arabinose were used in <italic>E. coli</italic> and <italic>S.</italic> Typhimurium LT2, respectively. Abbreviations: aa, amino acid; ATF, artificial transcription factor; a. u., arbitrary units; BS, binding site; JUB1, JUNGBRUNNEN1; JUB1-0X, synthetic promoter without binding site of JUB1-derived ATF; MFI, mean fluorescence intensity; RNAP, RNA polymerase; RFU, relative fluorescent unit; sfGFP, super-fold green fluorescent protein; TF, transcription factor. The full data are shown in <xref ref-type="supplementary-material" rid="SD3">Data S3</xref>.</p></caption><graphic xlink:href="EMS158002-f004"/></fig><fig id="F5" position="float"><label>Fig. 5</label><caption><title><italic>Salmonella</italic> biosensor responsive to alkaloid.</title><p><bold>a</bold> Schematic of the genetic circuit used in SALSOR 0.1 strain. The RamR sensor’s native constitutive promoter (present in <italic>S.</italic> Typhimurium LT2) was implemented to express RamR. Expressed RamR targets a synthetic promoter consisting of RamR sensor’s operator BS<sub>RamR</sub> and UP element, followed by RiboJ-RBS (75 nucleotide sequence consisting of a satellite RNA of tobacco ringspot virus derived ribozyme followed by a 23-nucleotide hairpin immediately downstream to help expose the RBS)<sup><xref ref-type="bibr" rid="R43">43</xref>, <xref ref-type="bibr" rid="R45">45</xref></sup> that controls sfGFP expression. In the presence of NOS, RamR interaction with BS<sub>RamR</sub> is inhibited. <bold>b</bold> Schematic of the genetic circuit used in SALSOR 0.2 strain. Plasmid-encoded JUB1-derived ATF is expressed in the presence of 0.05% arabinose. A synthetic promoter containing four copies of JUB1 BS fused to weak P<sub>BBa_J23117</sub><sup><xref ref-type="bibr" rid="R24">24</xref></sup> was used to express RamR sensor. The expressed RamR targets a synthetic promoter consisting of BS<sub>RamR</sub> and UP element, followed by RiboJ-RBS<sup><xref ref-type="bibr" rid="R43">43</xref>, <xref ref-type="bibr" rid="R45">45</xref></sup> was implemented to express sfGFP. <bold>c</bold> Fluorescence response of RamR biosensors to NOS. The fluorescence output of SALSOR 0.1 and SALSOR 0.2 in the presence of 0.05% arabinose. WT is <italic>S.</italic> Typhimurium LT2. NOS<sup>+</sup>, 100 μM; NOS<sup>-</sup>, without NOS. To simplify the figure, the RBS upstream of ATF start codon and terminators are not shown. Data are expressed as the mean ± SD of the RFU obtained from three biological replicates. Asterisks indicate a statistically significant difference (<italic>t</italic>-test; ns, not significant; *<italic>p</italic> ≤ 0.05; ***<italic>p</italic> ≤ 0.001). To simplify the figure, the RBS upstream of ATF and terminators are not shown. Abbreviations: AD, activation domain; ATF, artificial transcription factor; a. u., arbitrary units; BS, binding site; JUB1, NAC TF JUNGBRUNNEN1; NOS, noscapine; RBS, ribosome binding site; RNAP, RNA polymerase; RFU, relative fluorescent unit; sfGFP, super-fold green fluorescent protein; TF, transcription factor; TSS, transcription start site; UP, upstream element; WT, wild type. The full data are shown in <xref ref-type="supplementary-material" rid="SD4">Data S4</xref>.</p></caption><graphic xlink:href="EMS158002-f005"/></fig><fig id="F6" position="float"><label>Fig. 6</label><caption><title>Production of β-carotene in <italic>E. coli</italic> strains.</title><p><bold>a</bold> Schematics showing the β-carotene production from bacterial FPP precursor. CrtB, phytoene synthase; CrtY, lycopene cyclase; CrtI, phytoene desaturase; CrtE, geranylgeranyl pyrophosphate synthase. <bold>b</bold> Scheme showing the β-carotene-encoding plasmids used in this study. pK2151200 is results of assembly of BioBricks K118014 (RBS+crtE), K118006 (RBS+crtB), K118005 (RBS+crtI) and K118013 (crtY) in single operon (constructed by Glasgow iGEM 2016). In plasmid pK2151201, bacterial constitutive strong promoter <italic>J23106</italic> (designed by J. Anderson, iGEM2006) controls the expression of the synthetic crtEBIY operon. c Scheme representing production of β-carotene using JUB1-derived ATF. In plasmid pCAROTENE5X, <italic>J1</italic>-derivative synthetic promoter containing five copies of plant JUB1 TF, fused to P<sub>BBa_J23117</sub><sup><xref ref-type="bibr" rid="R24">24</xref></sup>, controls the expression of “crtEBIY” operon. A JUB1-derived ATF donor contains <italic>P<sub>BAD</sub>,</italic> the full length of JUB1 TF, 5-aa linker<sup><xref ref-type="bibr" rid="R24">24</xref></sup>, SoxS(R39A)<sup><xref ref-type="bibr" rid="R24">24</xref></sup> (that is optimized for expression in <italic>S.</italic> Typhimurium). It additionally encodes KanR. The donor is flanked by 40-bp homology arms to integrate into the <italic>att186</italic> site<sup><xref ref-type="bibr" rid="R39">39</xref></sup>. To simplify the figure, the RBS upstream of ATF and terminators are not shown. d Analysis of carotenoid content of <italic>E. coli</italic> strains. The JUB1-derived ATF donor was integrated into the <italic>att186</italic> site of <italic>E. coli.</italic> Followed by pCAROTEN5X transformation, β-carotene production was quantified in the presence of 0.2% arabinose (WT/pCAROTENE5X). Representative culture of the constructed β-carotene producing strains were shown in top. The β-carotene absorbance at 450 nm was measured using the method reported by Lian <italic>et al</italic><sup><xref ref-type="bibr" rid="R46">46</xref></sup>, and was divided to cdw. The data were normalized to that of the WT. Values represent the mean ± SD of three independent colonies in the presence of 0.2% arabinose. <italic>E. coli</italic> strains containing pK2151200 (WT/pK2151200) and pK2151201 (WT/pK2151201) were used as controls. Asterisks indicate a statistically significant difference (<italic>t</italic>-test; ns, not significant; ***<italic>p</italic> ≤ 0.001). “<italic>X</italic>” inside the columns represents the fold induction compared to WT/pK2151200. Abbreviations: aa, amino acid; AD, activation domain; ATF, artificial transcription factor; BS, binding site; cdw, cell dry weight; JUB1, FPP, farnesyl pyrophosphate; GGPP, geranylgeranyl pyrophosphate; NAC TF JUNGBRUNNEN1; KanR, kanamycin resistance marker; RBS, ribosome binding site; TF, transcription factor; WT, wild type. Full data are shown in <xref ref-type="supplementary-material" rid="SD5">Data S5</xref>.</p></caption><graphic xlink:href="EMS158002-f006"/></fig></floats-group></article>